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Abstract 
Mathematical Modeling of Nitric Oxide Transport Mechanisms 
Kathleen Ann Lamkin-Kennard 
Dov Jaron, Ph.D. 
 
 
 
 Nitric oxide (NO) is a powerful vasodilator that plays an important role in normal 
physiological and pathophysiological conditions.  The primary goal of this research was to 
advance the understanding of the interacting mechanisms between NO, O2, hemoglobin, blood 
flow, and multiple chemical species in the microcirculation under steady state and non-steady 
conditions.  The general approach was to develop and validate a non-linear cylindrical 
diffusion-reaction mass transport model based on experimental data to analyze these factors.  
Different from prior studies in the literature, this study simulates the effects of multiple 
cylindrical vessel layers, coupled NO and O2 transport, O2-dependent production from different 
NOS isoforms, time-dependent transport and chemical reactions, convective transport, arteriole-
venule pairing, dynamic changes in vessel diameter, and multiple chemical species including 
superoxide and peroxynitrite.  In addition, numerous factors affecting NO and O2 availability 
such as viscosity, hematocrit, the Fähraeus effect, oxygen saturation, pH, and CO2 were 
modeled. 
 Specific findings from this study suggest: that NO and O2 transport are fundamentally 
intertwined; that NO can help enhance O2 delivery to distal tissue regions, particularly at low 
PO2 values; that NO production from nNOS can help augment normal vasodilatory functions; 
that production of NO from iNOS and nNOS could act as a protective mechanism in 
pathological conditions; that the Fähraeus effect is significant in vessels less than 30 µm in 
diameter and leads to higher predicted NO concentrations; that arteriole-venule pairing acts to 
increase peak endothelial and tissue NO concentrations; that, due to differences in reaction 
times for different chemical species, non-steady state conditions should be included to capture 
any transient effects; convective transport significantly influences axial NO gradients and 
xvi 
downstream vessel concentrations; and that, at even relatively low production rates, superoxide 
is a potent scavenger of NO.  Overall, this study illustrates how mathematical modeling can be 
used as a powerful tool to understand interactive mechanisms affecting NO transport that often 
cannot be analyzed experimentally.  This holds great promise for understanding disease 
processes associated with NO dysfunction and can assist in the development of novel treatment 
strategies or clinical therapeutics.    
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1 
CHAPTER 1 : INTRODUCTION 
 
 
Nitric oxide (NO) is a powerful vasodilator released by the vascular endothelium that has 
received a great deal of attention in recent years for its role in both physiological and 
pathophysiological conditions.  In addition to regulating vascular tone, NO also inhibits adhesion 
molecule expression and platelet aggregation, and prevents vascular smooth muscle cell 
proliferation (Griffith and Edwards, 1990; Panza et al., 1999).  Abnormalities in NO transport 
have been implicated in numerous disease processes including essential hypertension, 
atherosclerosis, sepsis, glaucoma, renal failure, diabetes mellitus, and neurodegenerative 
disorders.  The importance of NO in regulating blood flow and metabolism is well established 
however, the mechanisms by which it is transported and its interactions with components in blood 
and tissue have not been fully elucidated. The primary goal of this research was to advance our 
understanding of the interacting mechanisms between NO, hemoglobin, O2, blood flow, and 
oxygen free radicals in the blood and tissue.  The general approach was to develop and validate a 
non-linear cylindrical diffusion-reaction mass transport model based on experimental data and 
use it to analyze these factors. 
1.1 Nitric Oxide  
NO is formed from the guanidine-nitrogen terminal of L-arginine by the enzyme NO 
synthase (NOS), which has 3 major isoforms:  eNOS found in endothelial cells, nNOS found in 
NO producing neurons, and cytokine-inducible iNOS.  A mitochondrial enzyme (mtNOS) may 
also exist (Bates et al., 1995, Ghafourifar et al., 1997, Giulivi et al., 1998), although there is 
controversy as to whether it is a true NOS isoform (Brown, 2001).  These isoforms differ in 
function, amino acid sequence, post-translational modification, and cellular location (Mayer, 
2000).   O2 is required for enzymatic synthesis of NO from L-arginine, therefore O2 availability 
affects NO production rates for all three major NOS isoforms (Buerk, 2001, Clementi et al., 
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1999).  Once NOS is maximally activated, the rate of NO generation depends primarily upon 
available concentrations of L-arginine and O2.  
Activation of constitutive NOS (eNOS and nNOS) depends upon intracellular Ca2+ and 
calmodulin (Kuchan et al., 1994), although some studies suggest there may also be a Ca2+-
independent pathway.  Increased Ca2+ promotes binding of Ca2+-calmodulin to eNOS and nNOS, 
displacing caveolin to produce NO (Panza et al., 1999).  Increases in Ca2+ can be stimulated by 
acute increases in shear stress or by activation of G-protein coupled cell surface receptors. 
Therefore NO release can be modulated by changes in shear stress exerted on the arterial wall by 
flowing blood or by agonists in the bloodstream.  Fluid shear stress due to blood flowing through 
a vessel exerts a force on the luminal surface of the endothelium.  Under basal conditions, the 
endothelial cytoskeleton is maintained under tension.  When an external stimulus is applied, 
intracellular tension is redistributed over the cytoskeletal network.  This architecture permits 
forces to be directly transmitted from the cell surface, through the cytoskeleton, and across 
physically interconnecting filaments to the nucleus (Mayer, 2000).  These changes in force lead to 
the activation of eNOS through mechano or mechano-chemical signaling processes (Busse and 
Fleming, 1998; Ballerman, 1999; Mayer, 2000).  Factors affecting the blood velocity, including 
fluid viscosity and the physical dimensions of blood vessels determine the shear stress action on 
the endothelium.  Mean (time-averaged) shear stress tends to be highest in small arterioles (60-80 
dynes/cm2) and has been shown to cause a steady NO response during stimulation and a biphasic 
rise in Ca2+ concentration.  Neurohumoral mediators (e.g. acetylcholine), circulating hormones 
(catecholamines and vasopressin), autoacoids generated within the vascular wall (bradykinin and 
histamine), or mediators released by platelets (serotonin, ADP) or formed during coagulation 
(thrombin) can also cause the release of NO through activation of specific endothelial receptors 
(Mayer, 2000).   
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The inducible isoform (iNOS) does not require Ca2+ for activation. It can be induced in 
tissue by macrophages in response to endotoxins or cytokines.  Excessive NO production has 
been implicated in inflammation and septic shock.  
  Constitutive NOS isoforms have been shown to play an important role in control of 
vascular tone (Gocan et al., 2000). After formation, NO diffuses to vascular smooth muscle cells 
and stimulates soluble guanylate cyclase (sGC), resulting in increased cyclic 3’5’-guanosine 
monophosphate (cGMP) and vasodilation.  This process catalyzes the conversion of guanosine 
triphosphate to cGMP and leads to the relaxation of smooth muscle cells (Ohno et al., 1993).  
Some studies have found evidence that, in the absence of eNOS, other vasodilator pathways 
compensate to preserve vascular tone.  In eNOS-deficient (genetic knockout) mice, nNOS has 
been suggested as a mechanism by which vasodilation is maintained in the coronary circulation 
(Lamping et al., 2000).   In atherosclerotic vessels, increased nNOS expression was found to be 
associated with decreased expression or activity of eNOS, suggesting a possible compensatory 
mechanism (Wilcox et al., 1997).  
1.1.1 NOS Biochemistry 
The NOS enzymes are polypeptides containing an N-terminal oxygenase domain and a 
C-terminal reductase domain.  The molecular weights of these proteins have been shown to range 
from 140 – 150 kDa for nNOS and eNOS and are ~200 kDa for iNOS (Chen et al., 1996; Crack et 
al., 1998).  Between the two domains is an approximate 30-amino acid recognition sequence for 
calmodulin.  The oxygenase domains of the different NOSs contains a core region that binds 
heme, tetrahydrobiopterin, L-Arginine, and forms the active site where NO synthesis takes place 
(Mayer, 2000).  The N-terminal region of the oxygenase domain is located upstream from the 
core region and varies in length between the different NOS isoforms.  The N-terminal  region 
participates in cellular targeting and may affect NOS structure or catalysis (Mayer, 2000).  The 
reductase domains of the NOS isoforms bind flavin mononucleotide, flavin adenine dinucleotide, 
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and NADPH (Mayer, 2000).  During NO synthesis, the reductase flavins obtain electrons from 
NADPH.  These electrons are then transferred to the heme iron, which permits it to bind and 
activate O2 and catalyze NO synthesis.  In the constitutive NOS isoforms, the flavin to heme 
electron transfer is triggered by calmodulin binding.  The flavin to heme electron transfer is 
proposed as the mechanism by which calcium and calmodulin regulate NO synthesis from these 
isoforms.  Certain proteins have been shown to inhibit or induce constitutive NOS activity, such 
as caveolin or heat shock proteins (e.g. Hsp90), although the mechanisms are not yet well 
understood (Mayer, 2000). 
NO production has been shown to be dependent on extracellular L-arginine 
concentrations.  Circulating L-arginine concentrations range from 50 – 200 µM, however levels 
within endothelial cells can reach concentrations of 800 µM or higher (Hardy and May, 2002).  
The affinity of purified eNOS for L-arginine is in the low µM range (Km < 5 µM), suggesting that 
the enzyme operates under saturating substrate concentrations and should not respond to changes 
in extracellular L-arginine concentrations (Hardy and May 2002).  However, studies have also 
shown that L-arginine supplements enhance endothelial-dependent vasoactivity (Clarkson et al., 
1996; Cooke and Tsao, 1997; Lerman et al., 1998).  The dependence of eNOS on extracellular L-
arginine despite saturating intracellular levels of L-arginine is known as the ‘arginine paradox’.  
Hardy and May (2002) suggest that the paradox can be explained by regulated L-arginine uptake 
into a compartment that contains eNOS and that is distinct from bulk cytosolic L-arginine.  The 
compartment may be associated with the caveolae (Hardy and May, 2002).  However, future 
experimental work is needed to determine if such a compartment.exists and its precise location.   
Under steady state, NOS circulates in an active cycle that generates NO and an inactive 
cycle that involves formation and decay of the heme-NO complex (Mayer, 2000).  NOS 
molecules start in a NO-free form during the active cycle, however once NO formation occurs, 
NO can bind to the enzyme molecules shifting the molecule to the inactive cycle.  Decay of the 
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NO complex enables NOS to become active once again, thus the enzyme can circulate in and 
between inactive and active cycles (Mayer, 2000).   
1.2 NO-O2 Interactions 
  There is evidence that NO directly influences O2 transport to tissue by at least four 
mechanisms (Buerk, 2001):  (1)  O2 effects on NO production (2)  Delivery of NO to perivascular 
tissue and its interactions with O2 (3)  O2 dependent interactions between NO and Hb to regulate 
blood flow and O2 delivery and (4)  NO reactions with thiols in the presence of O2.   
1.2.1 NO Synthesis 
Oxygen is required for the synthesis of NO from L-arginine.    The general oxidation 
reaction that occurs during a NOS active cycle to synthesize NO is  
    NOcitrullineLOArginineL +−→+− 2
The generally accepted theory for how this process occurs is that heme reduction leads to O2 
binding and a stepwise activation of heme-bound O2.  Activation of the heme-bound O2 generates 
the oxidant species that participate in NO synthesis (Mayer, 2000).  Experimental evidence 
suggests that distinct iron-oxygen species are involved in each step of NO synthesis although the 
precise mechanisms and distinct species are not well characterized (Sato et al., 1998). NO 
production in the above reaction can be assumed to follow Michaelis-Menten kinetics, thus O2 
dependent NO production can be represented by  
          (1) )KC/(CRR mOOmaxNONO += 22
where Km is the Michaelis constant corresponding to the O2 concentration (C )at half of the 
maximum NO production rate (R
2O
NOmax) and RNomax is the maximum NO production rate (Buerk, 
2001). 
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1.2.2 NO Reactions 
1.2.2.1 Auto-oxidation 
 
  NO reacts readily with oxygen and oxygen-derived radicals.  The reaction between NO 
and O2 to form nitrite (NO2-) is known as autooxidation.  The oxidation reaction between NO and 
O2 forms NO2, which then decomposes to NO2- by the following set of reactions 
    22 22 NOONO →+
    322 ONNONO →+
    +− +→+ HNOOHON 22 2232
The kinetics of this reaction are second order in NO and first order in O2 in aqueous environments 
such that  
   
2
2
oNO
NO CkC
dt
dC =        (2) 
 where k is a general reaction rate constant, CNO is NO concentration, and is O2OC 2 
concentration.  This reaction occurs in the bloodstream, vascular wall, and tissue in microvessels, 
however, published rate constants for this reaction suggest that auto-oxidation has only minor 
influences on NO diffusion compared to other factors, such as reactions with hemoglobin or sGC, 
and may be neglected in most cases (Buerk, 2001).     
1.2.2.2 Oxygen-Derived Radicals 
Superoxide (O2•-) is an oxygen-derived free radical that reacts rapidly with NO anion to 
form peroxynitrite (ONOO-) 
−− →+ ONOOONO 2  
The reaction with superoxide is the most rapid biological reaction for NO, however it may be 
limited by the reaction between O2•- and superoxide dismutase (SOD).  Superoxide can be 
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generated from a variety of sources including NADPH oxidase, xanthine oxidase, the 
mitochondrial electron transport chain, or NOS itself, in the absence of L-Arginine (Buerk, 2001).  
The reaction to produce ONOO- has important implications for biological systems since it leads 
to loss of bioactive NO.  Excessive superoxide production has been shown to be associated with 
numerous disease processes including diabetes mellitus, hypertension, atherosclerosis (Loscalzo 
and Vita, 2000).  Peroxynitrite also reacts with NO to form nitrogen dioxide radical (NO2-) and 
nitrate (NO3-).    
1.2.2.3 NO Effects on Mitochondrial O2 Consumption 
  Cytochrome c oxidase is responsible for about 90% of oxygen consumption in mammals 
and is necessary for nearly all energy production in cells (Brown, 2001).  It is located in the 
mitrochondrial inner membrane.  NO binds rapidly and reversibly to the oxygen binding site of 
cytochrome oxidase.  Studies by Brown (1999, 2001) showed that NO added to isolated 
cytochrome oxidase caused immediate inhibition of oxygen consumption that was reversed when 
the NO was broken down.  The amount of inhibition by NO is dependent on O2 availability.  NO 
was shown to have little effect on respiration when the concentration of O2 is much greater than 
NO (O2:NO ratio is > 250:1) (Buerk, 2001).  The competition between NO and O2 at cytochrome 
oxidase acts to increase the apparent Km for oxygen (Brown and Cooper, 1994).  A linear 
relationship between Km and NO has been reported in several studies (Koivisto et al., 1997; 
Brown and Cooper, 1994; Thomas et al., 2001).   
1.2.3 Hemoglobin 
Conventional thinking suggests that NO reacts with deoxy- and oxy-hemoglobin at a very 
high rate to form nitrosyl-hemoglobin and methemoglobin, respectively (Kosaka et al., 1999; 
Kosaka, 1999; Liao et al., 1999; Mayer, 2000).  The reaction is proposed to inactivate NO.  
According to in vitro data, a half-life of approximately one µsec should exist for NO in blood, 
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yielding concentrations too low to activate guanylate cyclase.  These conclusions were apparently 
confirmed by early modeling analyses (Lancaster, 1994), however, later studies suggested the 
scavenging rates used in early modeling studies may have overestimated the scavenging rate by 
red blood cells and that other mechanisms may be present in the blood that help preserve NO 
bioactivity.  For example, the release of NO or nitrosylated thiols from S-nitrosyl hemoglobin has 
been suggested as a mechanism to package and transport NO (Stamler, et al., 1997, Gow and 
Stamler, 1998, McMahon and Stamler, 1999, Gow et al., 1999, Gross and Lane, 1999, Patel, 
2000).  External diffusion limitations due to an undisturbed boundary layer surrounding each red 
blood cell (RBC) or an RBC-free zone near the vessel wall have also been suggested to reduce 
the rate of NO consumption by RBCs (Liao et al., 1999).   
1.2.3.1 Diffusion Theories   
Studies by Liao et al. (1999), suggested that NO consumption by RBCs is slower than by 
free hemoglobin by an approximate three orders of magnitude and that intravascular flow reduces 
NO consumption by RBCs, but not by free hemoglobin.  The RBC-free zone varies with shear 
stress and can be as much as 20-25% of the lumen diameter in thickness (Sharan and Popel, 
2002).  The RBC-free zone was suggested to contribute to the decreased consumption of NO by 
RBCs, but does not completely explain the low NO consumption rate by RBCs.  In cases without 
an RBC-free zone, consumption by RBCs was still calculated to be lower than by free 
hemoglobin (Liao et al., 1999).  In this study, the impact of the RBC-free zone, in conjunction 
with the well known Fahraeus Effect, was modeled to analyze effects on NO bioactivity.  
Suggestions were also made that the undisturbed layer surrounding RBCs creates 
sufficient diffusion resistance to prevent consumption by red blood cells.  Vaughn et al. (2000) 
suggests that NO produced from the endothelium must go through multiple steps to react with 
RBC-enclosed hemoglobin: diffusion through the RBC-free zone to the bulk solution;  diffusion 
from the bulk solution to the RBC surface; diffusion across the RBC membrane;  diffusion and 
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reaction inside the RBC cytosol.  Experiments by Vaughn et al. (2000) suggested the presence of 
diffusional resistance, although the significance of the effects under physiological conditions has 
not been established. More recent mathematical models for interactions between NO and 
hemoglobin in the bloodstream have been developed (Huang et al., 2001, Kavdia et al., 2002, 
Tsoukias and Popel, 2002).  Resistance to NO transport around a single red blood cell (RBC) was 
modeled by Tsoukias and Popel (2002) to predict NO scavenging rates in the presence and 
absence of hemoglobin O2 carriers.  Results from their model suggested that the difference in NO 
uptake by intact RBCs and free hemoglobin is hematocrit dependent and smaller than previously 
reported by Liao et al (1999). Huang et al. (2001) proposed that resistance to NO transport in the 
RBC membrane might be due to NO-inert proteins which form a significant diffusion barrier. 
However, the model by Tsoukias and Popel (2002) does not support this conclusion. 
Liu et al. (1998), suggested that the rate of reaction between NO and intraerythrocytic 
oxyhemoglobin can be decreased by 600-700 fold due to the trapping of NO within hydrophobic 
compartments in cell membranes.  This theory has also been suggested to contribute to the 
presence of diffusional resistance although this effect could also be an important factor in 
protecting the nitrosative chemistry reactions described below.     
1.2.3.2 Fähraeus Effect  
  In the microcirculation, the two-phase nature of blood becomes important due to the low 
hematocrits reported in microvessels and the similarities in size between the vessel diameters and 
red blood cell diameters (Ye et al., 1995, 1998).  Some known effects that can be attributed to 
these properties include: the existence of a cell-free or cell-depleted layer near the wall; the 
Fähraeus Effect, in which the vessel hematocrit is a function of the tube diameter; the Fähraeus-
Lindqvist effect , in which apparent viscosity is dependent on the tube diameter; and the presence 
of blunt velocity profiles in microvessels.  Bugliarello and Sevilla (1970) measured cell velocity 
distributions in glass tubes under steady flow conditions.  Recently, Sharan and Popel (2001) 
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utilized data from Bugliarello and Sevilla (1970), in conjunction with their mathematical 
modeling studies, to illustrate how the thickness of the plasma layer, or cell-free layer, varies with 
vessel diameter.      
  Robin Fähraeus suggested that in microvessels with diameters below ~100 µm, the 
fractional volume occupied by red cells in microvessels (tube hematocrit, HT), is always lower 
than the flow fraction of red cells (discharge hematocrit, HD) since the average red cell velocity is 
higher than the mean blood velocity (Goldsmith et al., 1989).  The average red cell velocities are 
greater than that of the plasma due to the conservation of the number of erythrocytes and 
hemoglobin (Pries et al., 1986).  One consequence of the decreased transit time of erythrocytes 
through smaller microvessels is a decreased efficiency of O2 exchange (Ye et al., 1994).  Since 
NO transport is inherently linked to O2 transport through effects on NO production, particularly at 
low PO2s, and increases in tissue oxygenation, reduction in the efficiency of O2 release could lead 
to decreased NO production.  However, another consequence of the decreased transit time of 
erythrocytes is that less hemoglobin could be available for scavenging of NO.  A reduction in the 
scavenging of NO by hemoglobin could contribute to increased NO concentrations in blood.  To 
date, no NO transport models have incorporated the relative contribution of these effects, in 
conjunction with a cell-free layer, to examine their role in altering NO bioavailability.     
  The Fähraeus-Lindqvist effect refers to the observation that in blood vessels of diameter 
less than ~300 µm, the flow resistance of blood and other red cell suspensions decreases as vessel 
diameter decreases (Goldsmith et al., 1989).  The Fähraeus-Lindqvist effect could be attributed to 
a number of factors including a lower viscosity of the suspension due to the lower hematocrit in 
the vessel as a result of the Fähraeus effect, a rheological effect of a nonuniform distribution of 
cells across the vessel lumen, or the failure of the suspension to behave like a contiuum 
(Goldsmith et al., 1989).  This phenomena was not included in the described simulations, but 
could easily be incorporated into future simulations of convective transport. 
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  Experimental studies have shown that the velocity profiles of microvessels are slightly 
blunted from parabolic.  The blunting can be attributed in part to the distribution of cells in the 
vessel and the differences in viscosity between the cell rich and cell free zones.  The velocity 
profiles used in this study were assumed to be parabolic without blunting.  Sharan and Popel 
(2001) present a model that includes blunted velocity profiles, where varying degrees of bluntness 
can be simulated.  The equations used in their model could be adapted to the model described in 
this dissertation in the future, enabling incorporation of blunted velocity profiles.    
1.2.3.3 Carrier Theories   
Other ideas have emerged that hemoglobin acts as a carrier of NO rather than a scavenger 
(Gross and Lane, 1999).  One theory is that S-nitrosylation of hemoglobin to form Cys β93-
nitrosyl hemoglobin (SNO-Hb) bypasses the scavenging problem since by this mechanism 
hemoglobin acts as a carrier rather than a scavenger (McMahon and Stamler, 1999; Gow et al., 
1999).  The theory is in contrast to traditional thinking, which states that NO elimination as NO3- 
is dominant and NO release is inconsequential.  The theory raises questions that measurements 
using oxyhemoglobin assays may underestimate NO production since these rely on the 
assumption that NO3- is the major pathway of NO inactivation (Gow et al., 1999; Gross and Lane, 
1999).    
Early research studies showed that nitric oxide only binds with heme groups (Gibson and 
Roughton, 1974; Moore and Gibson, 1995).  More recent research done by Gow and Stamler 
(1998) proposes that in the veins, hemoglobin exists in a T structure and binds to NO at the heme 
site to form iron nitrosylhemoglobin (Hb(FeII)NO).  At all oxygen saturation levels, the 
concentration of NO relative to hemoglobin is low. The excess of binding sites, combined with 
the cooperativity of ligand binding in oxyhemoglobin, enables the addition of NO to heme to act 
in competition with the oxidation reaction (Gow et al., 1999; Gladwin et al., 2000, McMahon et 
al., 2000).   
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Upon oxygenation, a T to R conformation change occurs and βFe(II)NO transfers NO to 
the β93 Cys group to form SNO-Hb (Moore and Gibson, 1975; Stamler et al., 1997; Gow and 
Stamler, 1998; Patel, 2000; Jia et al., 1996; Kosaka, 1999).  This is consistent with the finding by 
Jia , et al. (1996), that steady state levels of SNO-Hb occur in red blood cells.  Arterio-venous 
differences in SNO-Hb suggest that the protein acts as a NO donor in the circulation and helps 
maintain blood pressure by causing local vasodilation or constriction to match oxygen 
requirements (Jia et al., 1996 and Stamler et al., 1997).  Higher levels of SNO-Hb have been 
found in arterial blood to support this suggestion (Rossi et al., 1997; Gow and Stamler, 1998; 
Butler et al., 1998; McMahon and Stamler, 1999).  SNO-Hb is in equilibrium with S-nitrosothiols 
(RS-NO), such as S-nitrosoglutathione (GSNO).  When SNO-Hb circulates to the arterioles and 
capillaries, the S-nitrosothiol group is thought to be released.  Di-nitrosyl iron complex (DNIC) is 
also thought to be produced (Gow et al., 1999).  Since S-nitrosothiols are not scavenged by the 
heme, RS-NO would be maintained in an active state.  RS-NOs are thus hypothesized to regulate 
blood pressure through direct contact with the endothelial wall in the microcirculation or by 
transfer to the site of action in smooth muscle by way of low mass S-nitrosothiols, such as 
glutathione-SNO (Jia et al., 1996 and McMahon and Stamler, 1999).  RS-NOs have been shown 
to retain vasorelaxant activity, but are not subject to diffusional constraints imposed by increasing 
hemoglobin concentrations in the blood (McMahon and Stamler, 1999). 
A recent study suggests a new mechanism by which S-nitrosothiols contribute to NO-
related vasoactivity (Pawloski et al., 2001).   This study proposes that in human erythrocytes the 
formation of anion exchanger (AE1) - SNO at the membrane-cytosol interface promotes a 
deoxygenated structure in SNO-Hb and transfers NO to the membrane.  Upon deoxygenation, the 
SNO is thought to be released.  Thus, the anion exchanger is proposed as a mechanism by which 
SNO may be released from hemoglobin and contributes to vasodilatory activity. 
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Recent studies argue that while the SNO-Hb pathway exists, it is not the primary transport 
mechanism for NO.  Typically SNO-Hb, Hb(FeII)NO, and GSNO are in equilibrium in the blood 
(McMahon et al., 2000).  Gladwin, et al. (2000), presented experimental evidence that the NO-
heme pathways dominate in vivo and suggested that NO binding to heme groups is a rapidly 
reversible process.  They suggest that the predominant reaction of NO at the alveolar-vascular 
interface is with oxyhemoglobin to form nitrate and FeIII.  They also postulate that direct NO, 
NO+, or nitrite release from Hb(FeII)NO is a primary pathway for maintenance of vascular flow 
while SNO-Hb only serves as an intermediary pathway.  According to this theory, NO released 
from Hb(FeII)NO hemes could react with cysteine 93 and then be transported out of erythrocytes 
by transnitrosation with glutathione, in a mechanism similar to that proposed by McMahon, et al.  
(2000).  Another theory suggests that low concentrations of NO in blood (10-7 to 10-5 M) under 
partial oxygenation are scavenged by deoxyhemoglobin rather than oxyhemoglobin to form α(Fe-
NO)2β(Fe)2.  This product would act as a low affinity oxygen carrier that can deliver oxygen to 
tissue (Liao et al., 1999).   
1.2.4 Thiols 
 In human plasma, rapid loss of anti-oxidants, such as protein thiols, occurs upon exposure 
to NO or NO2 (Kelm, 1999).   In the presence of electron acceptors, thiols have been proposed to 
react with NO or the nitrosonium moiety (NO+) of NO to form RS-NO (Kelm, 1999; Clancy et 
al., 1990; Stamler et al., 1992).  This mechanism has been proposed as a storage mechanism for 
NO in the plasma (Kelm, 1999).  RS-NOs release NO without metabolism in the presence of 
metal ions such as copper and iron (Butler et al., 1998; Hogg, 1999). 
S-nitroso serum albumin (SNO-albumin) has the highest concentration RS-NO in human 
plasma while S-nitrosoglutathione (GSNO) and S-nitrosocysteine (CysNO) have lower 
concentrations (Kelm, 1999; Clance et al., 1990).  Speculation exists that NO exchange between 
high and low molecular weight thiol pools may occur.  This would enable stabilization of NO via 
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its intermediate SNO-albumin and enable SNO-albumin to serve as a reservoir for highly reactive 
and short-lived molecular weight nitrosothiols, GSNO and CysNO (Scharfstein et al., 1994; 
Jourd’Heuil et al., 2000).  GSNO and CysNO can readily pass through cellular membranes and 
gain intracellular access to target cells in tissue.  Studies suggest that SNOs may gain access to 
the intracellular environment via a transnitrosation mechanism catalyzed by cell surface thiols 
(Scharfstein et al., 1994). 
1.3 Endothelial Dysfunction and NO - Physiological Implications 
Endothelial dysfunction and impaired endothelial derived NO bioactivity are associated 
with numerous disease states (Gross and Wohin, 1995; Batainah and Raij, 1998, Drexler and 
Hornig, 1999; Boulanger, 1999).  Two common diseases associated with endothelial dysfunction 
are hypertension and atherosclerosis.  Numerous studies have confirmed the importance of NO on 
the regulation of blood pressure during hypertension.  In some models of hypertension, vascular 
NO is upregulated as a compensatory mechanism to attempt to return blood pressure to normal.  
In other cases, NO activity is decreased, leading to direct increases in systolic blood pressure 
(Loscalzo and Vita, 2000).  The mechanisms thought to contribute to decreased NO bioactivity 
include decreased NOS levels, decreased sGC activity, and increased NO degradation.  
Established atherosclerosis or the presences of risk factors, such as hypertension or 
hypercholesterolemia, lead to dysfunctions in eNOS signaling (Mayer, 2000).  Proposed 
mechanisms that may contribute to atherosclerosis include decreases in NO production, increases 
in NO inactivation, and decreases in sensitivity to NO (Loscalzo and Vita, 2000).  Other disease 
states associated with endothelial dysfunction include hypercholesterolemia, diabetes mellitus, 
congestive heart failure, ischemia/reperfusion, pulmonary hypertension, and vascular injury 
(Loscalzo and Vita, 2000).  In this study, simulations were performed to simulate excessive 
production of superoxide, a factor associated with hypertension and atherosclerosis. 
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There is currently a great deal of research to help elucidate the mechanisms of impaired 
endothelial function and associated NO bioactivity.  Defects have been proposed to occur in all 
phases of the pathway leading from NOS3 gene expression to the actions of NO on the vascular 
system (Loscalzo and Vita, 2000).  The general process involved in eNOS gene expression to 
endothelium-derived NO actions is seen in Figure 1.  Defects that can occur in this pathway are 
NOS3 poymorphisms, altered NOS3 expression and mRNA stability, impaired signal 
transduction between mRNA and eNOS, impaired eNOS substrate and cofactor availability, 
destruction of NO, and decreased responsiveness to NO.  Two of these defects, impaired eNOS 
substrate availability and destruction of NO are modeled in this study.  Understanding the 
mechanisms of “normal” NO bioactivity and transport can help further the understanding of 
impaired NO activity and its contribution to numerous disease states and lead to development of 
clinical therapeutics to treat these conditions.   
1.4 Engineering Principles of Transport Phenomena 
Simulation of NO and O2 transport is dependent on fundamental equations of mass 
transport and fluid mechanics.  The following sections describe the general theory and equations 
related to diffusion and fluid mechanics needed to model these phenomena.  These principles are 
the theoretical basis used in development of the mathematical model. 
1.4.1 Diffusion 
Diffusion problems can be solved using a mass balance for a particular chemical species 
over a thin shell of solid or fluid (Bird, Stewart and Lightfoot, 1960).  The law of conservation of 
mass states that the {rate of mass in} – {rate of mass out} + {rate of mass produced by chemical 
reaction} = 0.  This is the basis for the diffusion equation.  If the mass balance is considered over 
a shell of finite thickness and the dimensions of the system become infinitely small, a differential  
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Figure 1. General processes involved in endothelium-derived NO action pathway (Adapted from Loscalzo 
and Vita, 2000).   
 
equation is generated.  The solution of this equation gives the distribution of that particular 
chemical species in the system.      
For mixtures consisting of two or more chemical species, a mass balance over an 
arbitrary differential fluid element can be used to establish the equation of continuity.  Assuming 
a constant density and diffusivity, the equation of continuity states 
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where Ci is the chemical species, v is the velocity component, D is the species diffusivity, and Ri 
represents a general chemical reaction.  For the case of zero velocity, this equation reduces to  
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which is also known as Fick’s second law of diffusion. 
1.4.2 Fluid Mechanics – Laminar Flow in a Tube 
Microvascular flow can be approximated as laminar flow in a tube (Fung, 1997; Carr and 
Lacoin, 2001).  For steady, flow of an incompressible Newtonian fluid in a rigid tube, the Navier-
Stokes equations become 
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where u represents the fluid velocity, µ is the viscosity, p denotes pressure, and the flow is 
considered in cylindrical polar coordinates r, θ, z.  If the flow is symmetric, this equation reduces 
to 
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Integration of the equation and assuming conditions of no slip at the vessel wall and symmetry at 
the center line yields a parabolic velocity profile 
 
dz
dp)ra(u 22
4
1 −−= µ        (7) 
where pressure (p) is a function of the position along the cylinder (z).  Integration of this equation 
yields the rate of flow through the tube.  Shear stress on the tube wall can be calculated by 
µ(∂u/∂r) at the vessel wall. 
1.5 Mathematical Modeling of NO Biotransport 
 Mathematical modeling studies have only occupied a small portion of the literature of 
NO investigation and have primarily dealt with the diffusion and scavenging of NO by 
hemoglobin.  Lancaster (1994, 1997) analyzed the intracellular and intercellular diffusion of free 
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NO using kinetic modeling and calculations of diffusibility and its reactions in aqueous solutions.  
The concentration field for a single cell was first examined, then a 41-cell compartment model 
was used to calculate the distribution of NO concentration around a collection of cells.  The study 
concluded that NO could not cause activation of guanylate cyclase, however these findings were 
later shown to be incorrect due to the oversimplified nature of the model and limited available 
experimental data at that time. 
Wood and Garthwaite (1994) simulated neuronal NO diffusion for synapses in the brain.  
Both single cell and continuum models were used to simulate NO signaling in neuronal activities.  
Kanai et al. (1995), created a mathematical model of NO diffusion, convection, and oxidation in a 
parallel plate flow chamber using bovine aortic endothelial cells to simulate an actual 
experimental set-up.  NO concentrations were measured at various positions along the flow 
chamber and a relation between NO release rate and shear stress was determined.  This analysis 
demonstrated the feasibility of modeling transport phenomena in a cell culture experiment; 
however, complex interactions among hemoglobin, oxygen, thiols, and other blood components 
were not examined.   
Butler et al. (1998), used Fick's law of diffusion to investigate NO migration within the 
vasculature.  The model used an infinite cylindrical source of NO to approximate the middle of a 
length of a blood vessel.  NO produced by endothelial cells was assumed to diffuse inward into 
the vessel and outward into the vascular smooth muscle.  A red blood cell free zone in the vicinity 
of the endothelium was included to reduce the scavenging effects by hemoglobin.  The 
concentrations at various distances were examined to determine if sufficient concentrations were 
present to activate guanylate cyclase.   
Vaughn et al. (1998) also used Fick's law of diffusion to determine the effective diffusion 
distance of NO in the microcirculation.  Three compartments were modeled, a vessel lumen, the 
endothelium, and an abluminal region corresponding to smooth muscle.  The model treated the 
endothelium as two singular surfaces displaced by the average thickness of a cell.  NO was 
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produced from both surfaces and diffused into both the luminal and abluminal regions.  Effective 
diffusion distances were examined for various size vessels and various hemoglobin scavenging 
rates both with and without a red cell free zone.  In both the Butler and Vaughn models, to obtain 
results consistent with experimental data, non-physiological reaction rates between NO and 
hemoglobin had to be used (Wood and Garthwaite, 1994; Roth and Wade, 1986; Buerk, 2001). 
Only one modeling attempt published to date has included O2-NO coupled transport. A 
recent study by Thomas et al. (2001) utilized the model previously done by Lancaster 
(1994,1997) to analyze the effects of oxygen and NO on tissue oxygenation.  This model was 
done using a planar geometry and assumed that the rate of NO disappearance is linearly 
dependent on oxygen concentration.  This study showed, consistent with previously published 
experimental results, that NO inhibits cellular mitochondrial oxygenation and extends the zone of 
adequate tissue oxygenation away from the blood vessel, particularly during conditions of 
increased oxygen consumption.  However, this study did not depict a cylindrical geometry and 
the first order rate constant for NO scavenging in tissue, which was determined experimentally, is 
much higher than used in previous modeling studies (75 times higher than Vaughn, et al. (1998)).  
Kavdia et al. (2001) recently presented a mathematical model of NO diffusion and 
reaction in the presence of hemoglobin based oxygen carriers (HBOC) for an arteriolar-size 
vessel.  Cell rich and cell free layers were modeled in the vessel lumen and the authors concluded 
that smooth muscle NO concentrations were significantly reduced when the extravasation of 
HBOC molecules was considered.  This study provided important insight into the effects of 
hemoglobin on NO transport, but did not consider O2-dependent NO properties, particularly NO 
production, or the intrinsic linkages between NO and O2 transport, leading to the overestimation 
of NO. 
No mathematical models published to date have simulated the transport and reactions of 
NO with thiols or SNO-Hb in vessels or tissue.  Additionally, none have addressed the 
possibilities that hemoglobin acts as a carrier for NO rather than a scavenger or that storage 
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mechanisms for NO may exist in vessels and tissue.  Shin et al. (2001) published a model of NO 
and S-nitrosoglutathione kinetics and transport in the human airways. This study utilized data 
from the existing literature to simulate steady state NO and S-nitrosoglutathione kinetics and 
transport in the bronchial mucosa for small and large airways.  A key objective of the study was 
to address the possibility that, in the airways, glutathione acts as a carrier molecule for NO.  
Based on the results of the simulation, the authors concluded that in the human airways 
catabolism of GSNO is relatively unimportant. This study provides a general methodology that 
could help in developing a model for blood and tissue; however the model parameters and 
conclusions cannot be directly applied to the microvasculature.   
More recent mathematical models for interactions between NO and hemoglobin in the 
bloodstream have been developed (Huang et al., 2001, Kavdia et al., 2002, Tsoukias and Popel, 
2002).  As previously described, resistance to NO transport around a single red blood cell (RBC) 
was modeled by Tsoukias and Popel (2002) to predict NO scavenging rates in the presence and 
absence of hemoglobin O2 carriers while Huang et al. (2001) proposed that resistance to NO 
transport in the RBC membrane might be due to NO-inert proteins which form a significant 
diffusion barrier.  Given the difficulties in measuring NO or NO-derived species experimentally, 
mathematical modeling of NO transport may be the most powerful method to further the 
understanding of NO biotransport and its role in normal physiological and pathophysiological 
conditions.   However, NO biotransport includes numerous simulataneous processes and 
interactions between multiple chemical species.  The previously mentioned mathematical 
modeling studies have addressed components of the NO transport process, however, none of the 
models coupled multiple factors affecting NO production and transport, particularly for a 
cylindrical geometry.  This dissertation addresses this need through development of a cylindrical 
diffusion-reaction coupled mass transport model.    
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1.6 Research Objectives 
 The general objective of this study was to develop a mathematical model of coupled NO 
and O2 transport in the microcirculation using model parameters from the literature to analyze 
interactive effects between NO, O2, blood flow, and hemoglobin in the microcirculation using 
modeling and computer simulations.  The study addressed the hypotheses:  that oxygen and shear 
stress are significant factors affecting NO production and its delivery to tissue; that NO affects 
oxygen transport and metabolism; and that mathematical modeling can be used as a quantitative 
means of analyzing these factors and provide guidance for experiments needed to further validate 
NO transport mechanisms.  
The specific objectives of the research were: 
• To develop a mathematical model of NO transport through multiple vessel layers 
for various size cylindrical microcirculatory vessels.  To solve model numerically 
using finite element methods.  To evaluate the effects of various model 
parameters on simulation results. 
• To couple the model of NO transport to O2 transport.   
o To simulate effects of O2 on NO production 
o To simulate effects of NO on O2 transport  
• To examine the effects of hematocrit and the two phase nature of blood on NO 
and O2 transport 
o To determine model geometry as a function of vessel diameter and 
hematocrit 
o To incorporate the Fähraeus Effect into simulations 
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o To determine effects of CO2, pH, and oxygen saturation on NO 
production and transport 
• To expand the model to simulate dynamic model effects, including changes in 
NO concentration.  To develop pilot simulations to illustrate how vessel diameter 
changes with shear stress 
• To incorporate additional chemical species, such as superoxide, into the model 
and the reactions of these species with NO and O2  
• To expand the model to include blood flow   
The study was performed in the microcirculation since the primary function of the 
microcirculation is the transport of nutrients to tissue and slight changes in arteriolar resistance 
can cause significant changes in blood flow throughout the body.  In addition, several properties 
of the microcirculation make mathematical modeling of the microcirculation more tractable.  In 
the arterioles and capillaries, the Reynolds number and Womersley number are less than 1 and 
flow becomes fully developed even in relatively short vessels.  As a result, the Navier-Stokes 
fluids equations simplify to the Stokes’ equation and inertial effects may be neglected.  If the two 
phase and Non-Newtonian nature of blood are not explicitly modeled for computational 
simplicity,  the fluid flow can be treated as a Poisseuille Flow and is more readily incorporated 
into equations of diffusive transport.   
1.7 Significance  
Despite a growing body of literature on the physiological role of NO, the precise 
mechanisms of action associated with NO remain largely unknown suggesting that there is a need 
to develop appropriate mathematical models of NO biotransport to fully understand different 
mechanisms (Buerk, 2001).  The use of mathematical models, based on and in conjunction with 
experimental data, should help elucidate the role of NO in areas ranging from control of smooth 
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muscle tone and blood flow to its roles in pathophysiological conditions.  The multidisciplinary 
nature of this research has significant implications for biological, clinical, and engineering 
science and applications.   
1.7.1 Biological  
Experimental observations have shown that NO has important functions in nearly every 
major system in the human body.   However, precise experimental measurement of NO is often 
difficult due to the highly reactive nature of this chemical species and interactive effects are often 
virtually impossible to measure experimentally.  As a result many physiological transport 
mechanisms and interactions associated with NO are not yet well understood.  The mathematical 
model developed in this study is an important tool that can be used to further understand these 
fundamental interactions and processes as well as general NO physiology.  One primary 
advantage of mathematical modeling studies is the effects of multiple interactions contributing to 
a particular transport mechanism can be included and the effects of each interaction isolated. For 
example, separate experimental studies have shown that O2 is needed for production of NO and 
that NO binds to cytochrome oxidase, inhibiting O2 consumption.  However, no experimental or 
modeling studies done to date have combined the two effects to evaluate the overall impact on 
NO and O2 transport in blood and tissue.  Through development of an interactive model, this 
research was able to quantify how decreases in O2 availability affected NO production as well as  
how NO helps compensate for decreases in oxygenation.  Through mathematical modeling, the 
relative contribution of each mechanism was isolated.  The model developed for this study can be 
used as the computational framework to synthesize new experimental data, to develop more 
sophisticated models of NO biotransport, and to enable testing of many of the hypotheses 
surrounding the formation and transport of NO.  This ultimately holds great potential for 
furthering the fundamental understanding of NO biology. 
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1.7.2 Clinical 
This research could also be used to improve our understanding of the relationship 
between NO and the pathophysiology underlying conditions such as atherosclerosis, essential 
hypertension, sepsis, or angiogenesis by examining the roles of O2, blood flow and associated 
shear stresses, and hematocrit on normal endothelial function (Moncada, 1991; Loscalzo and 
Vita, 2000;Mayer, 2000).  Many disease processes are associated with NO related complications 
of endothelial dysfunction.  Experimental studies have confirmed these findings in animal 
models, however, the mechanisms are not yet well understood.  Modeling the endothelial or other 
NO pathways could be used to easily predict effects associated with disruption of portions of the 
NO production and transport pathways.  Specific medical applications where the research could 
be used include development of blood substitutes and development of new pharmacological 
agents or modification of current pharmacological strategies.  For example, scavenging of NO by 
free hemoglobin in the absence of red blood cells is a significant problem that limits the use of 
hemoglobin-based blood substitutes clinically (Kavdia et al., 2001).  The model described in this 
dissertation can be used as an additional research tool to assist in the development of new blood 
substitutes by predicting systemic interactions between NO and hemoglobin.  As another 
example, the release of NO from compounds such as nitroglycerin has been established, however, 
the specific mechanisms by which these compounds affect the target site of action are not always 
known.  This research could provide a tool for simulating various mechanisms of action, thus 
enabling treatment strategies to be refined or new drugs to be developed.  In addition, modeling 
the interactions between NO, O2, and oxygen free radicals could help further the understanding of 
diseases related to oxidative stress and the role of superoxide dismutase or other chemical species 
in moderating these processes. 
 A great deal of research has recently emerged that described the importance of NO in 
angiogenesis and tumor growth (Thomsen and Miles, 1998; Reveneau et al., 1999; Lala and 
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Chakraborty, 2001; Xu et al., 2002).  High levels of NOS expression, particularly iNOS, have 
been shown in human cancers, including tumors in the stomach, breast, ovary, cervix, and central 
nervous system.  NO has been suggested to promote tumor growth and angiogenesis and selective 
inhibition of NOS or NO scavengers have been suggested as therapeutic strategies (Lala and 
Chakraborty, 2001; Morbidelli et al., 2003).  Mathematical modeling of the contribution of the 
different NOS isoforms in conjunction with experimental data could be used to advance our 
understanding of this important area of clinical research. 
1.7.3 Engineering 
This study involved development of a hierarchichal model that enabled investigation of 
complex interacting mechanisms and chemical species.  This research is one of the first attempts 
to expand existing modeling approaches to couple hemodynamics, multiple chemical reactions, 
and biophysical processes into a detailed integrated model.   The general methodologies used may 
be adapted by others looking to develop complex interactive dynamic simulations. 
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CHAPTER 2 : MATHEMATICAL MODEL DEVELOPMENT  
 
 
2.1 Introduction 
 This chapter describes the model geometry, assumptions, and governing equations used 
in development of the mathematical model.  The complete list of equations used in the model are 
presented in this chapter.  The specific equations used during each phase of model development 
and implementation are presented in the appropriate chapters later in the text.   This chapter also 
contains a description of the computer software FlexPDE (PDE Solutions, Antioch, CA) used to 
solve the model using finite element numerical methods.   
2.2 Model Geometry 
The mathematical model was developed using a cylindrical coordinate system.  The 
general model structure consists of symmetrical concentric cylinders as shown in Fig. 3A & B 
(side and front views).  In Fig. 2B, 0 < r < r1 corresponds to the flowing blood (RBCs) in the 
vessel lumen, r1 < r < r2 represents a thin plasma (RBC free) layer, r2 < r < r3 represents the 
endothelium, r3 < r < r4 represents the vascular wall, and r4 < r < r5 represents tissue.  As the 
model was expanded to include additional components, the vessel lumens were divided into cell 
rich and cell free (plasma) layers, using data presented by Sharan and Popel (2001).  The 
thickness of the cell free layer was assumed to vary as a function of vessel diameter and 
hematocrit (Bugliarello and Sevilla, 1970).   The cell free layer was also assumed to include the 
endothelial glycocalyx and its associated surface layer (Kavdia et al., 2001).  Additional layers 
were also added in the tissue region and at the outer vascular wall to expand the model and allow 
for the production of NO from iNOS and nNOS, respectively. 
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2.3 Assumptions   
The following general assumptions were made during model development.  For some 
simulations, additional conditions were imposed on the model or certain assumptions were lifted, 
e.g. steady state assumption.  Details are presented in the text for specific cases in which 
modeling assumptions were altered. 
 
(1) All simulations were for steady state concentration gradients.  
(2) NO was uniformly produced in the endothelium, and except for O2, adequate substrates, 
such as arginine, or other co-factors were present.  Other factors affecting production, 
such as Ca2+ or shear stress were not considered. 
(3) All layers were assumed to have homogeneous properties.  
(4) NO was assumed to be uniformly produced across the endothelium.   
(5) Axial NO and O2 gradients were assumed to be small due to the rapid reaction times of 
these species.   
(6) Concentration gradients were assumed to be constant in the circumferential (θ) direction.  
(7) Auto-oxidation in the bloodstream, vascular wall and tissue was assumed to be negligible, 
since the reaction rates between NO and O2 to form nitrite are low.  
(8) In the cell-rich region, changes in hematocrit resulted in directly proportional changes to 
the NO scavenging rate in the blood. 
(9) Temperature and 2,3-DPG concentrations remained constant during the simulation 
duration. 
(10) Blood was treated as a Newtonian fluid with low Reynolds number (Re < 1). 
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2.4 Governing Equations 
  The mathematical model was developed by treating the problem as a reactive flow 
modeling problem.  This approach incorporates convective motion of a fluid, chemical reactions 
among species, and diffusive transport processes while maintaining conservation of density, 
momentum, and energy (Oran and Boris, 1987).    The general non-linear diffusion-reaction 
equation used to model NO, O2, or other chemical species transport in the blood and through the 
various modeled layers was 
    
∑±∇⋅−∇=∂∂ → n iiiii RCvCDt
C 2
      (8)  
where Ci represents the species concentration (µM), i represents the species (0 = NO, 1 = O2, 
etc.), Di represents the diffusion coefficient for the ith species (µm2 s-1), and v represents the 
blood velocity (µm/sec).  The first term on the right side of the equation represents diffusion and 
the second represents the convective transport of the species.  The final term is the summation of 
n reactions (Ri) that are sink (-) or source (+) terms for the modeled species.   
 Chemical reaction expressions can be determined using the Law of Mass Action where the 
general chemical reaction is  and the rate is given as CBA k→+ ]N][N[k
dt
]N[d
BA
C = .  In 
this equation, [N] represents species concentration and k represents the rate constant.  For 
example, scavenging of NO in blood or tissue can be simulated using a first order expression, 
, where λiii CR λ−= i is the rate constant (s-1). 
 Equation 8 was used as the basic transport equation in each modeled layer with terms added 
or removed as a function of the modeling assumptions associated with that particular layer and 
the system boundary conditions.  The general model structure assumed that NO was produced in 
the endothelium and diffused radially into the vessel lumen and into the surrounding smooth 
muscle and tissue.  Additional equations were added within each layer to simulate additional 
30 
phenomena occurring in that particular layer, such as blood flow or NO production using 
expressions of Michaelis-Menten type kinetics.  The following sections describe the equations 
used within each layer.  The model was developed in a hierarchical fashion thus the equations 
describing the simplest model structure are presented first, followed by equations that were added 
to increase the model complexity.   
2.4.1 Vessel Lumen, including Cell Free Layer (r < r2)  
 The simplest model structure assumed that steady state NO diffusion occurs only in the 
radial direction and that red blood cells (RBCs) are the primary factor responsible for scavenging 
of NO.  Numerous studies have shown that NO is strongly scavenged by intact red blood cells 
and free hemoglobin (Carlson and Comroe, 1958, Cassolly and.Gibson, 1975).  If diffusion of 
NO is assumed to occur only in the radial direction and scavenging of NO by RBCs is assumed to 
be first order, Eqn. 8 reduces to 
 0=−


NOb
NONO C
dr
dCr
dr
d
r
D
b λ       (9) 
where  is the hemoglobin scavenging rate and is the diffusion coefficient for 
NO in blood.  The system is assumed to have a high enough Peclet number (ratio of convective 
transport to diffusive transport) in the axial direction such that axial diffusion can be neglected.  
Considerable variability exists in the literature for λ , ranging from ~100 s
Hbbb Ck=λ
b
bNOD
b
-1 (Liu et al., 1998) to 
~1000 s-1 (Kavdia et al., 2002).  To account for this variability, simulations were performed for a 
wide range of λ .  
 To more closely depict an in vivo geometry, the vessel lumen was divided into cell rich 
and cell free (plasma) regions.  The cell free plasma layer was assumed to contain an endothelial 
glycocalyx.  The radius of the cell free layer was determined as a function of the arteriolar 
diameter and the specified hematocrit based on Fi
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rich zone, scavenging of NO was assumed to occur primarily through reactions with hemoglobin 
in the RBCs.  Within the cell rich region, NO diffusion and scavenging was calculated using Eqn. 
2.  In the cell free zone, auto-oxidation was assumed to be the only mechanism responsible for 
scavenging NO (Kavdia et al., 2002) thus Eqn. 8 could be considered as  
0
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2 =−


ONOO
NONO CC
dr
dCr
dr
d
r
D
b λ      (10) 
where represents the rate constant for the auto-oxidation reaction between NO and O
2Oλ 2. For all 
simulations except those involving multiple chemical species, the auto-oxidation term in Eqn. 10 
was neglected.  
  Endothelial NO production is dependent on O2 availability in the bloodstream.  One 
primary objective of this research project was to model the effects of O2 availability on NO 
production and factors affecting this availability.   The first group of simulations developed for 
this disseration assumed that a fixed amount of O2 was available for production of NO (ie. blood 
PO2 was specified as boundary condition between vessel lumen and endothelium).  Later 
simulations explicitly calculated the amount of O2 available to the endothelium as a function of 
dissolved and bound O2, blood flow, and systemic hematocrit and hemoglobin concentrations.  
The two-phase nature of blood was also included in later simulations to account for the well-
known Fähraeus effect.  Other factors known to affect the oxyhemoglobin saturation curve, such 
as pCO2 and pH, were also modeled. 
  In the lumen, the total concentration of O2 was calculated as a function of the hematocrit. 
Changing the hematocrit altered the amount of O2 available for NO production and the species 
concentrations available for diffusion to tissue.  The Fähraeus Effect, known to affect the tube 
hematocrit (HT), was incorporated using data from Goldsmith et al.(1989) relating the ratio of 
HT/HD to vessel diameter.  Using this data, given a systemic hematocrit value and a specified 
vessel diameter, the vessel hematocrit (HD) can be calculated.  However, as illustrated by 
Goldsmith et al. (1989), the ratio of HT / HD varies greatly at most vessel diameters.  For example, 
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for a 20 micron diameter vessel, the ratio varies from 0.50 – 0.79 while for a 50 micron vessel, 
the ratio varies from 0.65 – 0.86.  To determine the significance of this range, simulations in this 
dissertation were performed using the lowest and highest ratio values.  The scavenging rate by 
hemoglobin in the cell rich region was reduced in direct proportion to the reduction in vessel 
hematocrit for all simulations. 
  In the cell rich region, the total concentration of oxygen in blood was calculated using  
        (11) )p(S*Hct*pc ObOO βα +=2
where αbO is the solubility of oxygen in blood (µM Torr-1), Hct is the average blood hematocrit, 
and  pO is the oxygen partial pressure (Ye et al., 1994).  In Equation 11, β is the oxygen-carrying 
capacity per unit volume of erythrocytes (ml O2 / 100 ml blood).  Assuming an average 
hematocrit, β can be expressed as 
  
Normalct )H(
]Hb[.341=β         (12) 
where [Hb] is the concentration of hemoglobin (g/ml blood) and (  is the normal value 
of hematocrit (Sharan et al., 1989).  S(p) is the oxygen dissociation function in blood and can be 
determined using the modified Easton’s formula (Buerk and Bridges, 1986) to express the 
oxygen-hemoglobin binding saturation  
Normalct )H
  011701486197410 .))
p
p.exp(exp(.)p(S *
O −


 −−=     (13) 
In Eqn. 13, p* is a characteristic partial pressure that is determined as a function of pH, 
temperature, CO2, and 2,3-DPG such that 
  


 −+−+−+−=
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In Eqn. 14, T is blood temperature, pCO2 is carbon dioxide partial pressure in blood, and G is the 
concentration of 2,3-DPG in blood (Ye et al., 1994).   
33 
 The model includes the dependency of pH on CO2 levels. The pH of blood can be calculated 
using the Henderson-Hasselbach equation, however, for this model a linear empirical relationship 
relating pH to pCO2 was used.  As described by Kelman (1966),  
  
02
2
100 ]pCO[
pCOlogkpHpH HH+=       (15) 
 where kHH is a constant, pH0 is 7.4, and [pCO2]0 is the pCO2 value at pH0.  This relationship, 
which is supported by experimental data, has been shown to be valid within a range of pCO2 
values from 20 to 100 mmHg.  Values for kHH range from –0.62 (Meldon, 1984) to –0.75 (Lee et 
al., 1969) in the literature.  For these simulations, a kHH value of –0.65 (Ye et al., 1994) was used.  
Equations 13-14 enabled the Bohr effect to be incorporated into the simulations (Popel, 1989).   
  Equations 10-15 were used to determine the oxygen content of the blood in the cell rich 
region.  In the cell free region, the hematocrit was assumed to be zero, thus the only contribution 
to the partial pressure was due to dissolved oxygen. In the cell rich zone, the partial pressure for 
O2 was calculated using the oxygen content and oxyhemoglobin saturation curve.  The calculated 
partial pressure was specified as the boundary condition for O2 at the interface between the cell 
rich and cell free regions and used to calculate the O2 diffusion-reaction profile in the cell free 
region.  The partial pressure at the endothelial-lumen interface was then used to calculate NO 
production from eNOS in the endothelium.  
  The most complex simulations in the vessel lumen incorporated blood flow.  For these 
simulations, a parabolic velocity profile was assumed and radial, axial, and convective transport 
effects were included.  The velocity profile was initially simulated as a parabolic profile to 
represent the distribution of the velocities of the red cells in the blood.  When radial, axial, and 
convective transport effects are considered, Eqn. 8 for NO becomes 
   02 =−−∇ bNONO dZ
dCvCD λ       (16) 
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where v is the velocity of the blood calculated from the parabolic velocity profile of the Hagen-
Poisseuille flow 
   
dz
dp)ra(v 22
4
1 −−= µ       (17) 
In this equation, µ is the viscosity of the fluid (cP), a is the radius of the cylinder, and dp/dz is the 
pressure drop along the vessel.  For a parabolic blood flow, Eqn. 17 can also be simplified to 
   


 

−=
2
1
a
rvv Max        (18) 
where vMax denotes the maximum velocity.  Integration of Eqn. 17 leads to the Poiseuille formula 
for flow ( Q ).  The shear stress at the cylinder wall is calculated using –µ(∂v/∂r) at r=a.  From the 
equations for the velocity profile and flow, the shear stress is calculated as  
.
   
dz
dpa
dz
dpa
a
Q
a
.
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π
π
µ
π
µτ      (19) 
where τ denotes shear stress (dyne/cm2).  
 As previously described, the total concentration of O2 in the blood consists of the total of the 
dissolved and bound components of O2.  Substituting Eqn. 11 into Eqn. 8 yields  
  02
2
2 =+−∇
dz
dS*Hct**v
dz
)C*(d
vC*D OO β
αα     (20) 
where α is the O2 solubility (µM/Torr) and S is the oxyhemoglobin saturation calculated from 
Easton’s equation, Eqn. 13.  Easton’s equation is differentiable with respect to thus dS/dZ 
can be calculated by invoking the chain rule for derivatives such that   
2O
C
  
dz
dC
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O
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α=      
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2.4.2 Endothelium (r1 < r < r2) 
 For O2 in the endothelium, Eqn. 8 simplified to 
  0
2
2 =−



eO
Oe R
dr
dC
r
dr
d
r
D
      (21) 
where De represents the diffusion coefficient in the endothelium. Eqn. 21 can also be expressed in 
terms of O2 partial pressure through Henry’s Law.  
The synthesis of NO from eNOS is O2-dependent, thus RNO was calculated in this region 
using the endothelial O2 concentration profile calculated from Eqn. 3.  The NO production rate 
(RNO ) was assumed to follow Michaelis-Menten kinetics (Buerk, 2001), represented as 
 
mO
ONO
NO KC
CR
R MAX+=
2
2          (22) 
where  is the maximum NO production rate (µM s
MaxNO
R -1) and Km  (Torr) is the O2 concentration 
at half of the maximum NO production rate.  The amount of O2 consumed for the synthesis of NO 
was assumed to equal the amount of NO produced.  NO production was assumed to occur 
uniformly across the endothelium, and was simulated using  
0=+


eNO
NOe R
dr
dCr
dr
d
r
D
       (23) 
where (µM s
eNO
R -1) represented the O2 dependent production of NO from eNOS.     
2.4.3 Vascular Wall and Tissue 
 In the vascular wall and tissue, NO concentrations were calculated using  
 0=+−


NONOt
NOt RC
dr
dCr
dr
d
r
D λ       (24)  
where  λ sGCsGCt Ck= t  is a pseudo-first order rate constant for NO scavenging by sGC, and Dt is 
the diffusion coefficient for NO in tissue (Buerk et al., 2003).  RNO is included in this equation for 
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simulations including NO production from iNOS or nNOS. Other chemical species (e.g. 
superoxide) might also contribute to tissue scavenging rates.  Values for λt ranging from 0.01 s-1  
(Vaughn et al., 1998a, 1998b) to 7.5 s-1 (Thomas et al., 2001) have been used in previous models 
of NO transport.  Ranges for λt are listed in Table 1. 
Tissue O2 partial pressures, computed as a function of O2 concentration and solubility 
(Henry’s Law), were determined from  
 0
2
222 =+−


m
max
O
AppKPO
POQ
dr
dPOr
dr
d
r
D α
    (25)  
where α is the O2 solubility.  The second term in Eqn. 25 represents a modified Michaelis-Menten 
O2 consumption rate, where QMax is the maximum metabolic rate (µM s-1) , and AppKm is the 
apparent Michaelis constant where 50% of the maximum occurs (Torr).  To represent the 
inhibitory effect of NO on O2 consumption, AppKm was assumed to increase linearly with NO 
(Buerk, 2001) as  
 )
nM
C(KappK NOmm 27
1+=        (26) 
where Km is the Michaelis constant in the absence of NO (assumed to be 1 Torr for 
allsimulations).  Similar linear relationships have been reported by Koivisto et al. (1997) and 
Brown and Cooper (1994).  Eqn. 26 provides the mathematical link between NO and O2 
metabolism for these simulations.  Calculated NO concentrations at each node in the finite 
element mesh were used in Eqn. 26 to determine AppKm values and subsequent effects on O2 
metabolism in the tissue region. 
2.5 Boundary Conditions   
To solve the above coupled sets of nonlinear differential equations, the following 
boundary conditions were used.  Zero flux was assumed at the center of the vessel lumen due to 
symmetry, yielding 
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 0=
dr
dCD ii   at   r = 0       (27) 
The mass flux of a species leaving one layer was assumed to equal the mass flux entering an 
adjacent layer to satisfy the continuity equation.  For example, at the luminal boundary (r2) 
mendotheliur
i
ilumenr
i
i dr
dCD
dr
dCD
11
|| −=−       (28) 
At the outer boundary of the tissue region (r5), concentration gradients of both species changed 
slowly and mass fluxes were assumed to go to zero  
 0=
dr
dC
D ii   at   r = r5        (29) 
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CHAPTER 3 : MODEL IMPLEMENTATION 
 
 
3.1 Introduction 
 This chapter describes the simulation procedures and mathematical methods used to 
implement the mathematical model.  The system of equations described in Chapter 2 needed to be 
solved numerically due to the non-linearities in the governing equations as a result of the 
interactions between chemical species.  This chapter also contains a description of the computer 
software FlexPDE (PDE Solutions, Antioch, CA) used to solve the model using finite element 
numerical methods.   
3.2 General Simulation Procedures 
Figure 3 represents the general computational procedures used in the simulations.  These 
procedures represent the steps used in simulations involving O2-dependent NO production and 
interactions between NO and O2 in tissue. The steps followed were:   
(1) Specify or calculate blood O2 concentration in vessel lumen  
(2) Calculate blood velocity profile (for convective simulations only) 
(3) Use O2 concentration and Eqn. 25 to calculate NO production in the endothelium.   
(4) Calculate NO concentration gradient in endothelium, vessel lumen, and entering 
vascular wall using Eqns. 9,23, and 24, respectively. 
(5) Calculate O2 concentration gradient in endothelium and Eqn. 21. 
(6) Calculate NO concentration gradient in vascular wall and tissue 
(7) Calculate appKm using calculated NO gradient from Eqn. 22 to simulate the 
inhibitory effect of NO on mitochondrial O2 consumption. 
(8) Calculate O2 metabolic rate for vascular wall and tissue using appKm 
(9) Calculate O2 concentration gradient in vascular wall and tissue 
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Figure 3.  General computational procedures used in simulations. 
 
For cases involving additional chemical species, the same general procedures described in steps 4 
– 8 were adapted to account for the presence of additional species 
NO modeling studies by Vaughn et al. (1998a, 1998b) assumed that NO concentrations 
~250 nM were needed to activate sGC, based on experiments by Stone and Marletta (1996).  
Recent modeling by Condorelli and George (2001) suggests that much lower NO concentrations 
can activate sGC, with predicted cGMP formation rates at 50% of maximum for NO 
concentrations less than 100 nM.  However, they suggest that further experimentation is needed 
to fully quantify sGC activity for NO below 100 nM.  For all simulations described in this 
dissertaion, the assumption was made that NO concentrations greater than 100 nM were sufficient 
to activate sGC. 
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3.3 Parameter Interactions 
The mathematical model incorporates numerous interactions between modeled 
parameters.  The primary parameters used in the model include 1) Diffusion coefficient of all 
species in the vessel lumen, endothelium, vascular wall, and perivascular tissue, Di 2)   Maximum 
O2 metabolic rates in the vascular wall and tissue, Q, 4)   Maximum NO production rates for 
eNOS, nNOS, and iNOS, RNOMax 5) Rate constants for scavenging in each region, λ, 6) Michaelis 
constants (Km) used to calculate O2–dependent NO production and NO-dependent O2 metabolism, 
7)  Oxyhemoglobin saturation, 8) systemic hematocrit, 9) axial pressure gradient driving fluid 
flow, and 10) model dimensions (particularly vessel diameter and length).  Values of parameters 
used for specific simulations are listed in each chapter with the associated simulations and were 
obtained from experimental data reported in the literature. Figure 4 illustrates the interactions 
between the different simulation parameters. 
3.4 Numerical Methods   
The sets of coupled nonlinear partial differential equations with associated boundary 
conditions were solved numerically using finite element methods.  The finite element method is a 
powerful computational tool that can be used to solve nonlinear partial differential equations.  
Finite element methods involve subdividing the problem domain into small subdomains called 
elements.  Elements are described by points at the vertices and on each edge called nodes.  The 
total collection of elements and nodes is known as 
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Figure 4 .  Interactions between model parameters. 
 
 
the finite element mesh.  Solution approximations of the governing partial differential equation 
are obtained at each node in the mesh.  By evaluating the solution approximations for the PDE at 
each node using specific test function, a system of equations is generated that can be solved 
iteratively.  The solutions are solved iteratively until the error tolerance is less than a specified 
target value or other stopping criteria are reached (e.g. finite number of iteration steps reached).  
In the software used for this study, FlexPDE, solutions are obtained once the solution error is less 
than the specified error tolerance for the system of equations. 
3.5 FlexPDE    
FlexPDE is a "scripted finite element model builder and numerical solver" that can solve 
problems in two or three dimensions.  Key features of this software package include a script 
editing module, a symbolic equation analyzer that expands defined parameters and relations to 
create symbolic Galerkin equations, a mesh generation module that constructs a triangular finite 
element mesh in 2-D, a finite element numerical analysis module that selects an appropriate 
solution scheme, and an error estimation function that assesses the adequacy of the finite element 
mesh and iterates the mesh refinement and solution until a specified error tolerance has been 
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achieved (www.pdesolutions.com, 2003).  Simulation outputs are displayed graphically within 
the graphical user interface and can be exported to other applications in numerous formats.  
Figure 5 illustrates the FlexPDE simulation interface during a simulation involving multiple 
chemical species.   
The FlexPDE software was chosen for use in this research for several reasons.  The 
FlexPDE scripting enables definition of multiple inter-connected layers with different boundary 
conditions.  Multiple coupled partial differential equations can be specified and solved in short 
computational times.  Adaptive meshing techniques allow larger numbers of elements in regions 
of steep concentration gradients.  This was an important feature in this research since several of 
the model regions had significantly different thicknesses, such as the endothelium (2 µm 
thickness) and the tissue region (100 µm thickness).  Figure 6 illustrates a sample finite element 
mesh with a greater number of nodes in and near the endothelial surface.  The consistency of the 
numerical solutions was verified using various specified error tolerances to ensure that the 
solutions were independent of the error tolerance.  Solutions were also checked analytically, 
where computationally feasible.   
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Figure 5.  FlexPDE Simulation Interface. 
 
 
Figure 6.  Sample finite element mesh, sliced along z-axis.  Endothelial thickness = 2.0 µm, vascular wall 
Tissue 
Vascular 
wall 
Endothelium 
Vessel  
lumen 
thickness = 9 µm, and tissue thickness = 50 µm.  
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3.6 Cases Simulated 
The mathematical model was developed in multiple phases.  During each phase, the 
complexity of the model progressively increased.  Subsequent chapters describe the mathematical 
modeling methods, results, and discussion associated with each of the cases listed below:   
• Case 1:  NO Transport 
• Case 2:  Coupled NO-O2 transport – Interactions in tissue.   
• Case 3:  O2-Dependent NO Production 
• Case 4:  O2-Dependent NO Production – Different NOS isoforms 
• Case 5:  Cell Rich and Cell Free Layers   
• Case 6:  Fähraeus Effect 
• Case 7:  Arteriole-Venule Pairing 
• Case 8:  Dynamic Effects 
• Case 9:  Changes in Response to Changes in Shear Stress 
• Case 10:  Additional Chemical Species 
• Case 11:  Convective Transport  
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CHAPTER 4 : MODEL OF NO TRANSPORT  
 
 
4.1 General Description  
The simplest case simulated was for a 50 µm diameter cylindrical arteriole 400 µm in 
length with radial NO diffusion into the blood vessel and surrounding tissue.  Only two regions 
were included in these simulations, the vessel lumen and surrounding tissue (100 µm tissue 
thickness).  A fixed NO concentration was specified at the interface between the vessel lumen and 
the tissue.  This interface was assumed to be the endothelium.  NO was assumed to be scavenged 
by red blood cells in the vessel lumen and sGC and other factors in tissue.  Different scavenging 
rate constants were used in these simulations to examine the effects of these parameters on NO 
concentration profiles.  The solution for this set of conditions can be obtained analytically and 
was used to verify numerical simulations.   
4.2 Methods 
Steady NO transport in tissue can be represented using a one-
dimensional radial diffusion equation.   
  0=±

 ∑
n
i
NO R
dr
dCr
dr
d
r
D
      (30) 
where D represents the diffusion coefficient and Ri is the sum of 
all scavenging or production reactions that may occur.  The 
geometry of the problem can be considered as two concentric 
cylinders with an inner cylinder of radius r1 = 25 µm and an 
outer radius of r2 = 125 µm as seen below.  The inner cylinder is 
assumed to represent the vessel lumen and the outer cylinder is 
assumed to represent the vascular wall and surrounding tissue.  
The interface between the two regions is assumed to be the 
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vascular endothelium 
and is the site of NO 
production.  NO produced by 
this surface diffuses 
radial in both directions. 
 r2 
r1 
Endothelium 
Lumen 
Tissue 
 
 
 
 
 
 
 
Figure 7.  Schematic representing model layers including the blood vessel, 
endothelium, and surrounding tissue.  In this figure, r1 is 25 µm and r2 
is 125 µm. 
 
 
In the blood with first-order scavenging of NO by hemoglobin in 
red blood cells, Eqn. 30 becomes 
  0=−


NOb
NO C
dr
dCr
dr
d
r
D λ       (31) 
where λb is a pseudo-first order rate constant. In the tissue with 
combined first-order scavenging of NO by soluble guanylate 
cyclase or other scavenging reactions this becomes 
0=−


NOt
NO C
dr
dCr
dr
d
r
D λ       (32) 
If a fixed concentration of NO is assumed to occur in the 
endothelium, the NO concentration can be specified as a boundary 
condition along r1 such that NO(r1) = 100 nM.    To solve these 
equations, zero flux is assumed at the center of the vessel (r=0) 
and at the outer tissue boundary such that 
  0
0
=
=r
NO
dr
dC
 and 0
2
=
=rr
NO
dr
dC
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4.3 Results 
The general solutions to equations 31 and 32 are 



+


= r
D
Kcr
D
IcC bbNO
λλ
0201        (33) 
and  



+


= r
D
Kcr
D
IcC ttNO
λλ
0403       (34) 
respectively, where c1, c2, c3, and c4 are arbitrary constants that can be determined from the 
boundary conditions and I0 and K0 are zeroeth-order modified Bessel functions of the first and 
second kind.  Solving for the constants in blood and tissue, , yields 
 Blood:  
10
0
r
D
I
r
D
I
b
b
NO λ
λ
C =        (35) 
Tissue:  
21101021
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D
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D
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D
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D
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D
K
C
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tttt
NO λλλλ
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+
+
=C    (36) 
where the subscript denotes either blood (b) or tissue (t), C0 is the endothelial NO concentration, 
and I1 and K1 are first-order modified Bessel functions of the first and second kind.     
4.4 Validation 
Figure 8A provides a comparison of results obtained analytically from Eqn. 32 in the 
tissue region for different tissue scavenging rates (green line) and numerically using finite 
element numerical methods in Flex PDE (black line).  Differences between the analytical and 
numerical solutions can be seen in Figure 8B.  The maximum difference between the analytical 
and numerical solutions was ~1 nM in the region of the peak NO concentration (1%).  These 
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small differences between numerically and analytically obtained solutions suggest that good 
correlation exists between the two methods, particularly for low λt. This favorable comparison 
confirms the validity of the numerical methods. 
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Figure
using 
B.  DiBA 8.  A.  NO profiles in tissue for different scavenging rates.  Green lines represent solutions obtained 
analytical methods.  Black lines represent solutions obtained using numerical methods in FlexPDE.  
fferences between concentrations obtained using numerical and analytical solutions. 
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CHAPTER 5 : COUPLED NO-O2 TRANSPORT - INTERACTIONS IN TISSUE 
 
 
5.1 Description 
The next modeling phase incorporated radial diffusion of NO and O2 in a 50 µm arteriole 
of length 400 µm.  This group of simulations includes the assumption that NO inhibits 
mitochondrial O2 consumption in tissue.  This phenomena was incorporated into the simulations 
using the Michaelis-Menten type kinetics in Eqn. 25.  A fixed NO production rate was specified 
in the endothelium.  Four different model regions were simulated.    In contrast to earlier 
simulations, the tissue region was divided into a vascular wall region and a tissue region.    In 
vivo, the metabolic rate of the vascular wall is much lower than the metabolic rate of the tissue 
and other modeling studies of O2 transport have confirmed the importance of including the 
vascular wall (Ye et al., 2998, Vadapalli et al., 2000).  For these simulations, different maximum 
metabolic rates in the vascular wall and tissue were used to more closely mimic in vivo 
conditions.  Expansion of the model to include the vascular wall provided the model structure 
needed to incorporate production of NO from nNOS in the outer vascular wall in later 
simulations.  The model dimensions and parameter values used for this group of simulations can 
be found in Table 1.   Different scavenging rates in tissue were included to determine the effects 
of these parameters on modeled transport.   
5.2 Methods 
The following sections describe in detail the equations used for the simulations to couple 
NO and O2 transport in the tissue region.  The equations and methodology are presented in full 
detail here since the general form of the equations is an integral component of all subsequent 
simulations.   
51 
Table 1.  Model Parameters Used to Simulate NO and O2 Interactions 
 
DEFINITION    VALUE(S)   
 
Vessel Geometry 
  
 Vessel Length   300 - 400.0 µm  (Ye et al., 1994) 
 
Vessel Diameter   20.0 – 100.0 µm (Ye et al., 1994) 
 
Plasma Layer Thickness  2.0 – 6.2 µm (Sharan and Popel, 2001) 
 
Endothelium   2.0 µm  (Buerk, 2001) 
 
Vascular Wall   9.0 µm  (Vadapalli et al., 2000) 
 
Tissue Thickness   100.0 µm (Vaughn et al., 1998; Butler, 1998) 
 
Hematocrit    45% 
 
Solubility Coefficient (α)  1.3 µM Torr-1 (Buerk, 2001) 
 
 
Diffusion Coefficients (D) 
 O2     2.8 x 10-5 cm2 s-1 (Ye et al., 1994) 
 
 NO     3.3 x 10-5 cm2 s-1 (Buerk, 2001) 
 
Maximum O2 Consumption (QMax)  
 
Vascular wall   5.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
Tissue    50.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
 
Hemoglobin Scavenging (λb)   382.5 s-1 (Carlson and Comroe, 1958)  
 
 
Tissue Scavenging (λt)   0.01 s-1 – 10.0 s-1 (Vaughn et al., 1998,  
          Thomas et al., 2001) 
 
Km Values 
eNOS    4.7 Torr (Rengasamy & Johns, 1996) 
 
O2      1.0 Torr (Buerk, 2001) 
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5.2.1 NO Equations 
NO concentration profiles were obtained in each layer using the steady state, one-
dimensional radial diffusion equation.  In the blood stream, the equation incorporates first-order 
scavenging of NO by hemoglobin in red blood cells and is given by  
  0=−


NOb
NO C
dr
dCr
dr
d
r
D λ       (37) 
where D is the diffusion coefficient, CNO is the NO concentration, and λb is a pseudo-first-order 
rate constant for blood.  Similar equations are used for the plasma layer, endothelium, and tissue.  
In  plasma 
   0=


dr
dCr
dr
d
r
D NO        (38)  
In the endothelium, 
  0=+


NO
NO R
dr
dCr
dr
d
r
D
      (39) 
where RNO is a source term for NO production by endothelial cells.  In the vascular wall and 
surrounding tissue 
    0=−

 NOt
NO C
dr
dCr
dr
d
r
D λ                              (40) 
where a pseudo-first-order rate constant for NO scavenging, λt, is assumed (Buerk, 2001).  
Simulations were done using a vessel hematocrit equal to the systemic hematocrit (45%) and a 
zero NO flux boundary condition at the outer tissue boundary 
5.2.2 O2 Equations 
The general equation used to model steady state oxygen transport was  
  0
2
22 =+−



m
Max
O
appKPO
POQ
dr
dC
r
dr
d
r
D
iα     (41)  
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where D and S are the diffusivity and solubility for O2, respectively and  Qmax is the maximum 
metabolic rate.   A constant blood PO2 was assumed for these simulations, thus the boundary 
condition used was 
ttanconsbloodPOPO
r
== 222    
For simulations that included the vascular wall, QMax Wall < QMax Tissue.  Values for QMax can be 
found in Table 1.  Equation 41 predicts the inhibitory effects of NO on O2 consumption and 
neglects any O2 loss due to autooxidation.  The second term on the right side of the equation 
represents modified Michaelis-Menten kinetics where Km increases linearly with NO 
concentration, 
  )
27
1(
nM
C
KappK NOmm +=       (42) 
In this equation, Km is the Michaelis constant in the absence of NO (assumed to be 1 Torr for 
these simulations). 
5.3 Results 
Figure 9A compares simulation results with and without interactions between NO and O2 
to simulate inhibition of O2 consumption through binding to cytochrome oxidase.  Note in this 
figure that O2 concentrations with a fixed tissue metabolism (independent of NO) are lower than 
concentrations with a tissue metabolism that is a function of NO.  Figure 9B compares O2 profiles 
with and without inhibition of O2 consumption for different blood PO2 values.  For these 
simulations, production was assumed to occur from eNOS only.  In distal tissue regions, the 
increases in O2 delivery to distal tissue regions were proportionally greater at lower PO2 values 
than at higher PO2 values.  Figure 9C shows how the Km values change as a function of radial 
position in the vessel.  Note that the lowest Km values occur in the distal tissue region.   
Simulations were performed for different levels of accuracy to verify that the simulation results 
were independent of the finite element error tolerance.  Table 2 compares NO concentrations at 
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different points in the lumen and tissue for different simulation accuracies.  Note in this table, that 
error limits greater than 0.001 have little impact on simulation results, but do significantly 
increase the computation time.   
Simulations were run with and without a vascular wall region to compare the effects on 
NO and O2 concentration profiles as seen in Figure 10.  Observe in these figures that including 
the vascular wall resulted in slightly higher O2 concentrations in the distal tissue regions 
illustrating the potential importance of including this layer in the model geometry.  Note also that 
inclusion of the vascular wall did not affect NO concentration profiles significantly.    
5.4 Discussion 
Studies have shown that NO binds to cytochrome oxidase leading to an inhibition of O2  
consumption (Brown and Cooper, 1994; Brown, 1999).  The mathematical model illustrates that 
this inhibition of O2 consumption acts to increase tissue PO2, particularly in distal tissue regions.  
Further details regarding these general findings are presented later in Chapter 6 for simulation 
results including O2-dependent NO production and production from other NOS isoforms. Overall, 
the results are in general agreement with Thomas et al. (2001), 
however this model incorporates a more realistic geometry and 
reaction rate constants.  Increases in distal O2 concentrations 
are more pronounced at low tissue PO2 values, suggesting that NO 
may act as a protective mechanism to enhance oxygenation under 
pathophysiological conditions (Knowes and Moncada, 1992; Brown 
and Cooper, 1999; Thomas et al., 2001; Brookes et al., 2002).      
The lowest K
m
 values were shown to occur in the distal tissue 
regions as seen in Figure 9C.  The distibution of K
m
 values 
suggests that NO inhibits O2 consumption most in the tissue 
region closest to the endothelium and less in the distal tissue 
regions.  These findings are seemingly contradictory to the 
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findings seen in Figure 9A in which the greatest increases in O2 
concentration  occur in the distal tissue region.  Figure 9C 
illustrates that the mechanism contributing most to the increased 
concentrations in the distal regions, the increased K
m
 value, is 
actually occurring in the regions of the tissue closest to the 
endothelium and vessel lumen.  The higher levels of consumption 
near the endothelium combined with the lower concentration levels 
in the distal regions result in the greater increases tissue O2 
concentrations seen in the distal tissue region. 
The vascular wall was shown to have virtually no effect on NO 
transport for the wall and tissue metabolic rates used in this 
simulation.  However, including the vascular wall slightly 
increased O2 availability in the distal tissue region.  If 
different tissue metabolic rates were used that more 
significantly influenced the O2 profile, the vascular wall could 
become more important in affecting NO transport.  This would 
occur due to the zero flux boundary condition assumed in the 
simulations.  For example, elevated distal O2 concentrations 
would elevate the O2 concentrations in the vascular wall and 
endothelium, leading to additional O2 availability for NO 
production.  These effects would most likely be slight, however 
the wall should be included for completeness.  Since inclusion of 
this segment does have slight effects on one of the modeled 
species and does not significantly increase computational times, 
it is included in all future described simulations.  Inclusion of 
the vascular wall is particularly important for understanding the 
NO concentrations that are available for reaction with sGC.  The 
vascular wall will also become more important for simulations 
incorporating nNOS production.  Inclusion of the vascular wall 
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could also become more important if the model were expanded to 
more explicitly include transport resistance properties of the 
vascular wall in the future (Vadapalli, 2000). 
 
Table 2.  Comparison of Peak Endothelial NO Concentrations for Different FEM Error 
Tolerances. 
Error Limit Peak Endothelial NO (nM) CPU Time (min:sec) 
0.01 102.5 0:04 
0.001 83.897 0:37 
0.0001 83.654 2:59 
0.00001 83.654 10:00+ 
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B 
A
Figure 9.  A.  O2 concentration profiles in 100 micron thick segment of tissue with and without interactions 
between NO and O2.  Results are compared for two different tissue scavenging rates.  B.  Comparison of 
PO2 profiles at different blood PO2 levels with and without NO dependent O2 metabolism.  C.  Plot of NO-
dependent Km values in tissue. 
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igure 9 (continued) 
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Figure 10.  Comparison of NO and O2 profiles with and without vascular wall. 
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CHAPTER 6 : O2-DEPENDENT NO PRODUCTION 
 
 
6.1 Description 
 As previously described, O2 is required for the synthesis of NO and can be modeled using 
Michaelis-Menten type kinetics.  This group of simulations expands the model to include O2-
dependent NO production from eNOS and simulated the effects of different NO production rates 
and hemoglobin and tissue scavenging rates.  NO was assumed to be uniformly produced in a 2 
µm thick endothelium.  NO produced by the endothelium diffused into the vessel lumen and into 
the surrounding vascular wall and tissue (lumen diameter = 50 µm; vascular wall thickness = 9 
µm; tissue thickness = 100 µm).  The vessel lumen was divided into cell rich and cell free 
(plasma) layers to more closely mimic in vivo conditions.  Comparisons of simulation results 
with and without the cell free layer are provided in Chapter 9.   
6.2 Methods 
The general equations used for these simulations are the same as those used in Chapter 5 
with the RNO production term expanded to include O2-dependent NO production rather than set at 
a fixed production rate.  As previously described, NO production can be modeled using 
Michaelis-Menten type kinetics and RNO can be calculated using Eqn. 22.  RNO was calculated 
simultaneously with the NO and O2 concentration profiles, thus the O2 terms used in Eqn. 22 are 
the O2 partial pressures calculated by the model.  The specific model parameters used for this 
group of simulations can be found in Table 1. 
6.3 Results 
 Figures 11A and 11B compare steady-state radial NO concentration profiles generated 
using NO production only from eNOS.  In Fig. 11A, NO gradients are compared for different 
values of  to illustrate the strong influence of NO scavenging by hemoglobin on model results.  bλ
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The highest tissue scavenging rate (λt = 7.5 s-1) was used for this simulation.  Note that as  
decreases, peak NO concentration in the endothelium increases.  The effect of tissue NO 
scavenging on steady-state radial NO profiles is shown in Fig. 11B for λ
bλ
t ranging from 0.01 s-1 to 
10.0 s-1, with λ  fixed at a high rate (Table 1). Peak endothelial NO was highest at the lowest 
tissue scavenging rate. Note that at the lowest hemoglobin and tissue scavenging rates, the peak 
endothelial NO concentration (~330 nM) is three times higher than the peak concentration 
simulated at the highest blood and tissue scavenging rates (~110 nM).  Figure 12 compares 
average NO concentrations in the vascular wall for different blood (λ
b
b) and tissue (λt) scavenging 
rates obtained by integrating the NO concentration over the area of the layer.  Average NO 
concentrations are greatest when the scavenging rates in blood and tissue are the lowest.     
6.4 Discussion 
Currently there is a limited understanding of what NO production rates are needed for 
NO to be an effective vasodilator.  Mathematical modeling to understand necessary production 
rates is particularly challenging due to the range of reported scavenging rates by hemoglobin, 
soluble guanylate cyclase, or other reactive species in blood and tissue (Buerk, 2001).  Changes in 
scavenging rates can lead to generation of varying NO concentrations in the endothelium and 
varying average NO concentrations available for reaction with sGC in the vascular wall.  Studies 
by Lancaster (1994, 1997), Butler (1998), and Vaughn et al. (1998) were the first to use 
mathematical modeling to predict NO concentration profiles.  These studies used relatively high 
scavenging rates, such as those for free hemoglobin, which led to prediction of low NO 
concentrations.  In contrast, the model described in this dissertation uses scavenging rates for 
intact red blood cells rather than free hemoglobin.  Free hemoglobin has a very high reported 
scavenging rate, several orders of magnitude higher than bound hemoglobin.  When scavenging 
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A 
B 
Figure 11.  NO profiles computed using O2-dependent NO production from eNOS for different blood and 
tissue  scavenging rates.  (A) Profiles are compared for different scavenging rates by hemoglobin at 100%, 
75%, 50%, and 25% of the scavenging rate reported by Carlsen and Comroe (1958). (B)  Profiles are 
compared for a range of tissue scavenging rates reported in the literature.   The dotted region represents the 
endothelium. 
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by free hemoglobin was used in the simulations described in this text, extremely low NO levels 
(for highest tissue scavenging rate, peak NO concentration < 5 nM) were obtained compared to 
simulations based on kinetic measurements with intact human RBCs (Carlsen and Comroe, 
1958).  These low concentrations are inconsistent with reported NO measurements (Buerk, 2001) 
suggesting the value for intact RBCs more closely represents conditions in vivo. 
 Reported NO scavenging rates in tissue range from as low as 0.01 s-1 (Vaughn et al., 
1998) to 7.5 s-1 (Thomas et al., 2001) or higher.  The primary scavenging factor in tissue is sGC, 
however, other factors also scavenge NO in tissue.  The value from Vaughn et al. (1998) may 
represent scavenging by sGC alone while higher values may include scavenging by other species, 
such as superoxide.  In Figure 11B, NO profiles generated with different tissue scavenging rates 
were compared.  For the case of the highest scavenging rates in blood and tissue, a three-fold 
decrease in NO concentration was observed from the case with the lowest scavenging rates.  At 
the highest tissue scavenging rate, the production rate would have to increase by ~23 µM s-1 to 
reach the NO concentration to the level generated with the lowest scavenging rate (~100 nM).  
These findings suggest that a for tissue scavenging rates ranging from 0.01 to 7.5 s-1, a range of 
NO production rates from 50 – 75 µM s-1, respectively, will yield a peak endothelial NO 
concentration of ~100 nM,.  For a wide range of tissue scavenging rates, this indicates relatively 
small differences between NO production rates are necessary to generate the same endothelial 
concentrations.  In similar simulations, for the same range of tissue scavenging rates, the 
endothelial NO production rates would need to be 105 – 155 µM s-1 or 160 – 235 µM s-1 to 
generate peak concentrations of 200 and 300 nM, respectively.  In vivo, the actual production 
rates may be even higher due to factors such as the Fähraeus effect or reactions with other 
chemical species, including superoxide.   
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Figure 12.  Average NO concentrations in the vascular wall computed from NO concentration profiles at 
two different tissue scavenging rates. 
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CHAPTER 7 : O2-DEPENDENT NO PRODUCTION – DIFFERENT NOS 
ISOFORMS 
 
 
7.1 Description 
 The model was further expanded to include NO production from nNOS and iNOS.  In 
addition to the generation of NO in the endothelium from eNOS, there was assumed to be an 
additional source of NO production from nNOS due to a group of nerves surrounding the vessel.  
To examine possible compensatory effects from nNOS during times of decreased eNOS activity, 
a 1 micron thick network of nNOS containing neurons was included in the outer vascular wall ( r 
= 8 µm to r = 9 µm ) taking into account  O2-dependent production of NO from nNOS based on 
Eqn. 22 and the O2 concentration in this region.   
 Another group of simulations assumed that in addition to NO generated in the 
endothelium, there was a 25 µm band of tissue (r = 75 µm to r = 100 µm) containing iNOS.  
Inclusion of iNOSwas done to simulate pathological conditions such as inflammation or sepsis.  
The additional NO production from iNOS was also O2-dependent and assumed to follow the 
Michaelis-Menten kinetics of Eqn. 22.  To satisfy the zero flux boundary condition for all tissue 
scavenging rates, the tissue thickness for the iNOS simulations was extended to 500 µm.   
 Km values for O2-dependent NO production from eNOS, nNOS, and iNOS listed in Table 
3 were reported by Rengasamy and Johns (1996).  Figure 13 compares NO production rates as a 
function of PO2, relative to production at PO2 = 85 Torr, for the 3 NOS isoforms.  At low PO2, 
peak NO production is more strongly influenced by changes in PO2 than at higher PO2 values, as 
indicated by the steeper slopes of the curves in this region.  Also, note that nNOS is the most O2-
sensitive isoform at low PO2.  
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Figure 13.   Effects of PO2 on NO production for three NOS isoforms.  The relationship for each isoform 
was normalized to the NO production rate when the PO2 was 85 Torr. 
 
 
7.2 Methods 
The general model methods used were the same as described in Chapters 5 – 7.  The model 
geometry was expanded to include two additional cylinders representing the nNOS production  
region and iNOS production region.  NO and O2 transport was assumed to follow the same 
behavior as described by Eqns. 40 and 41, however rather than the RNO term being set to zero as 
would normally occur in the wall or tissue regions, it was included to simulate production from 
the additional NOS isoforms.  NO production from iNOS and nNOS were assumed to follow the 
Michaelis-Menten type kinetics of Eqn. 22, however with different Km values.  Table 3 contains 
the model parameters and dimensions used for this group of simulations.    
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Table 3.  Model Parameters Used in iNOS and nNOS Simulations  
DEFINITION    VALUE(S)   
 
Vessel Geometry 
 
 Vessel Length   400.0 µm (Ye et al., 1994) 
 
Vessel Diameter   50.0 µm (Ye et al., 1994) 
 
Plasma Layer Thickness  2.0 µm  (Sharan and Popel, 2001) 
 
Endothelium   2.0 µm  (Buerk, 2001) 
 
Vascular Wall   9.0 µm  (Vadapalli et al., 2000) 
 
Tissue Thickness   100.0 – 500.0 µm  (Vaughn et al., 1998; Butler, 1998) 
 
Hematocrit    45% 
 
Solubility Coefficient   1.3 µM Torr-1 (Buerk, 2001) 
 
Diffusion Coefficients 
 
 O2     2.8 x 10-5 cm2 s-1 (Ye et al., 1994) 
 
 NO     3.3 x 10-5 cm2 s-1 (Buerk, 2001) 
 
Maximum O2 Consumption (QMax)  
 
Vascular wall   5.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
Tissue    50.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
Hemoglobin Scavenging (λb)   95.6 s-1 - 382.5 s-1 (Carlson and Comroe, 1958)  
 
Tissue Scavenging (λt)   0.01 s-1 – 10.0 s-1 (Vaughn et al., 1998,  
          Thomas et al., 2001) 
Km 
  
 eNOS    4.7 Torr  (Rengasamy & Johns, 1996) 
 
 iNOS    3.8 Torr  (Rengasamy & Johns, 1996) 
 
 nNOS    15.0 Torr  (Rengasamy & Johns, 1996) 
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7.3 Results 
7.3.1 Oxygen-Dependent NO Production from iNOS 
 Figure 14 compares NO profiles with O2-dependent production from eNOS and iNOS.  NO 
production was calculated using Eqn. 22 with Km values from Rengasamy and Johns (1996).  The 
effects of different tissue scavenging rates were included in Figure 14A to illustrate the 
significance of these rates in predicting NO concentrations.  In this figure, the peak NO 
concentration in the endothelium was not significantly affected by scavenging rates faster than 
5.00 s-1.   
 Figures 14B and 14C compare NO profiles with different NO production rates from iNOS and 
different tissue scavenging rates to illustrate how O2-dependent NO production from iNOS can 
elevate wall NO concentrations and act as a defense mechanism in pathological situations.  Note 
the differences in the magnitude of the NO production rates needed to increase NO concentrations 
delivered to the vascular wall and tissue between the two scavenging rates.  In Figure 14B, for a 
tissue scavenging rate set at 0.1 s-1, profiles were compared for NO production rates from iNOS 
ranging from 0 µM s-1 to 1.2 µM s-1.  In Figure 14C, a scavenging rate set at 7.5 s-1 was assumed 
with different production rates from iNOS ranging from 0.1 µM s-1  to 10 µM s-1.  Also note that 
with the scavenging rate set at a lower value (14B), production from iNOS increased the NO 
delivered to vascular wall and tissue for all production rates. However for the higher scavenging 
rate, production rates greater than 1.5 µM s-1 were needed to increase peak wall and tissue NO 
concentrations above endothelial concentrations.   
 Figure 14D compares the average NO concentrations found in the vascular wall with different 
NO production rates from iNOS.  Simulations were performed using high and low tissue 
scavenging rates.  Note in this figure, for iNOS the average NO in the wall increased linearly with 
increases in scavenging rate. 
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Figure 14.  NO profiles at different tissue scavenging rates with additional NO production from iNOS  (A)  
NO concentration profiles with production from iNOS and different tissue scavenging rates.  (B)  NO 
profiles with different production rates from iNOS with a tissue scavenging rate of 0.1 s-1.  (C)  NO profiles 
with different production rates from iNOS with a tissue scavenging rate of 7.5 s-1.  (D)  Average NO 
concentrations in the vascular wall for different tissue scavenging rates.   
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Figure 14 (continued)  
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7.3.2 Oxygen-Dependent NO Production from nNOS  
  Figure 15 compares NO profiles with O2-dependent production from eNOS and nNOS at 
different tissue scavenging rates to simulate the role of nNOS in elevating NO concentrations and 
augmenting vasodilatory effects.   Note that in Figure 15A, the peak NO concentration in the 
endothelium was not significantly affected by scavenging rates greater than 5.00 s-1.  Figures 15B 
and 15C compare NO profiles with different NO production rates from nNOS and different tissue 
scavenging rates.  In Figure 15B, results were compared for NO production rates from nNOS 
ranging from 1 µM s-1 to 10 µM s-1 and a tissue scavenging rate set at 0.01 s-1.  In Figure 15C, 
profiles were compared with different production rates from nNOS with a scavenging rate set at 
7.53 s-1.  Again note the differences in the magnitude of NO production rates needed to elevate 
NO concentrations delivered to the vascular wall and tissue between the two scavenging rates.  
For the lower scavenging rate, tissue NO concentrations were not elevated in the vascular wall 
and tissue for production rates less than 1.0 µM s-1.  However, for the higher scavenging rate, NO 
concentrations were not elevated for production rates less than 27 µM s-1.   
Figure 15D compares the average NO concentrations found in the vascular wall with 
different NO production rates from nNOS.  Simulations were performed using high and low 
tissue scavenging rates.  For nNOS, the average NO concentrations in the wall increased linearly 
as a function of the nNOS production rate for both high and low scavenging rates   
In Figure 16, simulations were run with fixed eNOS production rates and varying nNOS 
production rates at different PO2 values ranging from 85 to 5 Torr to illustrate how the O2 
sensitivity of nNOS affected NO levels delivered to tissue.   As the PO2 decreased nNOS 
production rates were increased to maintain an average wall concentration equal to that generated 
from eNOS alone.  This figure illustrates that at low PO2 values, higher NO production rates from 
nNOS were required to maintain the wall NO concentration.   
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Figure 15.  NO profiles at different tissue scavenging rates with additional NO production from iNOS  (A)  
NO concentration profiles with production from nNOS and different tissue scavenging rates.  (B)  NO 
profiles with different production rates from nNOS with a tissue scavenging rate of 0.01 s-1.  (C)  NO 
profiles with different production rates from nNOS with a tissue scavenging rate of 7.5 s-1.  (D)  Average 
NO concentrations in the vascular wall for different tissue scavenging rates.   
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Figure 15 (continued)   
74 
7.4 Effects of NO on Oxygen Transport for Different NOS Isoforms  
 Figure 17 compares O2 profiles with and without NO-dependent metabolism for the different 
NOS isoforms.  As can be seen in Figure 17A, NO increased O2 delivery to distal tissue regions 
for all three modeled NOS isoforms with the greatest effects due to the high NO concentrations 
generated by iNOS.  Figure 17B compares PO2 profiles with additional NO production from 
nNOS at different PO2 values.  Note that at high PO2 values, additional NO production due to 
nNOS significantly increased O2 delivery to distal tissue regions.  However, at low PO2 values, 
additional production of NO from nNOS had little effect in increasing O2 delivery.   
7.4.1 Discussion 
The three major NOS isoforms have previously been shown to have an inherent 
dependency on O2, particularly at low PO2 values (Buerk, 2001, Rengasamy and Johns, 1996). 
Simulations were performed at different blood PO2 levels for three NOS isoforms with a low 
tissue scavenging rate to computationally predict how this O2 dependency affects NO production 
in Figure 13.  As seen in this figure, at higher PO2 levels for eNOS and iNOS, slight decreases in 
PO2 do not significantly reduce NO production.  However, as PO2 levels decrease, NO production 
falls off more rapidly, particularly for nNOS.  The slopes of these three curves suggest that nNOS 
is the most sensitive to changes in oxygenation while iNOS is the least sensitive. The model 
predictions are consistent with reported findings presented in the literature and suggest that within 
a “normal” range of blood oxygenation, NO production from eNOS remains virtually unaffected.  
If eNOS were more O2 sensitive, slight decreases in O2 would lead to significant decreases in NO 
concentration and subsequent alterations in vascular tone and decreased O2 delivery to tissue.  
Fluctuations in NO production could result in changes in vascular tone leading to a relatively 
unstable vascular system.  This indicates that, in addition to its many other functions, through its 
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 Figure 16.  Ratio between eNOS and nNOS production rates at different physiological PO2 values.  The   
ratios were chosen to generate a certain target average NO concentration in the vascular wall.   
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Figure 17.  Comparison of PO2 profiles with and without NO dependent metabolism.  A.  Comparison of 
profiles with generation from different NOS isoforms.  B.  Comparison of O2 profiles for different PO2 
values and production from nNOS.     
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relative insensitivity to O2, eNOS may contribute to the basal stability needed for maintenance of 
vascular tone.   Figure 17B also illustrates the relative insensitivity of eNOS to changes in 
oxygenation.  The stronger dependence of nNOS on O2 suggests that NO concentrations 
generated from this isoform would be insufficient to increase tissue oxygenation to compensate 
for decreases in blood oxygen levels.  Isolating the relative contributions of NO on O2 delivery 
and O2 on NO production was easily done through computer simulations, but would be difficult 
to verify experimentally illustrating a key benefit of computer modeling to understand NO 
transport.   
As previously described, NO inhibition of mitochondrial O2 consumption could play an 
important role in regulating O2 delivery to distal tissue regions (Thomas et al., 2001).  Brookes et 
al. (2002) have recently suggested that mitochondria may provide a mechanism for cell signaling.  
Results from the model seen in Figure 17A, with NO production from eNOS, are consistent with 
the findings by Thomas et al. (2001) and suggest that production from eNOS would increase O2 
delivery to tissue.  Extending the model to include other NOS isoforms showed that combined 
NO production from eNOS and from other NOS isoforms leads to further increases in O2 delivery 
although the greatest influence on O2 delivery is due to eNOS rather than iNOS or nNOS due to 
the O2-dependency of these isoforms at low blood oxygenation.  
Many studies to date have modeled NO transport with production from eNOS, however 
until now none of the models have included O2-dependent NO production from additional NOS 
isoforms combined with O2-NO interactions.  While eNOS contributes to the maintenance of 
vascular tone, studies have suggested that production from other NOS isoforms may have 
significant effects, particularly during pathological conditions.  For example, as described by 
Wilcox (1997), during atherosclerosis, decreased expression or activity of eNOS has been shown 
to occur as well as increased nNOS expression.  This suggests that nNOS activity may act as a 
possible compensatory mechanism to help maintain vessel tone and reduce blood pressures 
during atherosclerosis.  The high level of NO production by iNOS during sepsis has been 
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suggested as a mechanism responsible for vasoconstriction and vasodilation deficits (Baker and 
Sutton, 1993, Hollenberg et al., 1993).  However, other studies in skeletal muscle suggest that it is 
likely upregulated nNOS rather than iNOS in septic muscle leading to impaired vascular 
responsiveness (Gocan, 2000).  Production from iNOS and nNOS were modeled to simulate these 
types of scenarios.   
Literature studies suggest that iNOS produces much higher concentrations of NO than 
eNOS, particularly during conditions such as sepsis (Buerk, 2001).   Using different NO 
scavenging and production rates, the mathematical model simulated the NO concentration levels 
produced during conditions such as sepsis and the relative sensitivity of these levels to blood 
oxygenation.  As seen in Figure 14 , NO availability for reaction with sGC is increased with 
additional NO production from iNOS for different scavenging and production rate combinations. 
For the lowest scavenging rates and a moderate production rate, NO concentrations reached 
values of ~400 nM in the tissue.  At the lowest scavenging rates, even very low production rates 
yielded high peak NO concentrations.  These elevated concentrations could explain the severe 
vasodilation observed clinically during conditions associated with increased NO production from 
iNOS.  For the entire range of scavenging rates simulated, the average NO concentrations were 
elevated in the vascular wall at least 10 – 200 nM above the levels produced from eNOS alone.  
These elevated wall concentrations suggest that NO production from iNOS could also 
compensate fully or at least partially for decreased NO production from eNOS by increasing 
average vascular wall NO concentrations. This further implies that iNOS could act as a defense 
mechanism in pathological situations.  To fully understand the effects of iNOS in elevating NO 
levels during pathological conditions and the production rates needed to generate these NO levels, 
additional model refinements could be included that more completely model the reaction kinetics 
associated with scavenging of NO by sGC (Condorelli and George, 2001, Bellamy and 
Garthwaite, 2001. 2002) or incorporate other chemical species.  For example, in addition to 
generating NO, under some conditions NOS can also produce superoxide (O2•-).  This would 
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lower the NO concentrations in the tissue requiring even greater values to elevate tissue NO 
concentrations, particularly at high tissue scavenging rates.   
Figure 15 illustrates how O2-dependent NO production from nNOS can lead to elevated 
NO concentrations in tissue for different NO scavenging and production rate combinations.  With 
additional production from nNOS, for different scavenging and production rate combinations, 
average wall NO concentrations were elevated by 30 to 90 nM over concentrations from eNOS 
alone.  These increases in average wall concentrations suggest that nNOS activity may act to 
augment vasodilatory effects or to compensate for decreased production from eNOS.  In Figure 
16, the effects of decreasing eNOS production rates and increasing nNOS production rates were 
simulated to mimic the condition described by Wilcox et al. (2000).  For these simulations, 
maximum nNOS and eNOS NO production rates were adjusted to generate an equivalent average 
NO concentration in the vascular wall equal to that generated from eNOS alone.  These 
simulations provide a computational means for testing how upregulation of nNOS could 
contribute to the maintenance of vascular tone, even in the presence of decreased eNOS activity.  
As PO2 values decreased, progressively higher nNOS production rates were needed to maintain 
the same wall concentration.  This corresponds to the nonlinearity seen in Figure 13 where NO 
production is more significantly decreased at low levels of O2.  At extremely low PO2 values, 
very high production rates from nNOS were needed to maintain the vascular wall concentraton, 
suggesting that at extremely low PO2 values, nNOS cannot fully compensate for decreased NO 
production from eNOS.   
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CHAPTER 8 : ARTERIOLE-VENULE PAIR 
 
 
8.1 Description 
Countercurrent exchange has been shown to be important in O2 transport (Yet et al., 
1995, 1998).  The model was expanded to simulate NO and O2 diffusion into tissue between an 
arteriole and venule pair as a preliminary simulation of countercurrent exchange.   Diffusion into 
a segment of tissue bounded by an arteriole (50 µm diameter) and venule (75 µm diameter) was 
modeled.  O2-dependent NO production was simulated in the arteriolar and venular endothelium.  
Different maximum NO production rates (RNOMax) were specified to simulate different 
experimentally reported conditions.  The first modeled scenario assumed that the maximum NO 
production rate was the same in both the arteriolar and venular endothelium.  The second group 
of simulations assumed that the maximum NO production rate was lower in the venular 
endothelium.  For both scenarios, results were compared for different tissue thicknesses and 
tissue scavenging rates.   
8.2 Methods 
This group of simulations were run in cartesian coordinates using the basic layered model 
structure, equations, and parameter values described in Chapter 5 and 6, with O2-dependent NO 
production and interactions between NO and O2 in tissue.  Each layer of the model geometry was 
modeled as a plane rather than as a cylinder, yielding a model structure consisting of a group of 
parallel planes rather than concentric cylinders.  The arteriole-venule pairing simulations were 
done in Cartesian coordinates to simplify the geometry and computational requirements in 
FlexPDE.  Simulation results can be assumed to be valid at all points that would occur on a line 
drawn between the centers of the two vessels and extending into the tissue region (Figure 18A).  
Convective transport and axial diffusion are assumed to be negligible in these simulations thus 
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model results would be valid between the center lines of the two vessels for all points along the z-
axis in cylindrical coordinates. 
Simulations were set up to represent two microvessels bounding a segment of tissue 100 or 
200 µm thick to represent arteriole-venule pairing.  The geometry was modeled in FlexPDE as a 
group of layers corresponding to the layers modeled in other simulations in cylindrical 
coordinates.  Diffusion was assumed to occur in the x-direction.  From left to right, the layers 
modeled were:  tissue, arteriolar endothelium, arteriolar plasma layer, arteriolar lumen, arteriolar 
plasma layer, arteriolar endothelium, tissue, venular endothelium, venular plasma layer, venular 
lumen, venular plasma layer, tissue (Figure 18B).  The vascular wall was not modeled explicitly.  
In these simulations, O2 concentrations were specified at the outer walls of the arteriole and 
venule lumens (85 Torr and 30 Torr, respectively) (Ye et al., 1994).  NO was assumed to be 
produced in the arteriolar and venular endothelium as a function of the O2 availability and 
diffused into the tissue segment.  Within the tissue segment, NO inhibition of O2 consumption 
was calculated.  
8.3 Results 
Figures 19 and 20 illustrate NO concentration profiles generated with equal NO production 
rates in the arteriolar and venular endothelium for tissue thicknesses of 100 (19A, 20A) and 200 
(19B, 20B) microns.  Comparisons are made for different scavenging rates.  In these figures, the 
peak concentrations in the arteriolar endothelium are greater due to the higher O2 concentrations 
in the arteriole.  Note in this figure, for both tissue scavenging rate and tissue thicknesses, the 
combined contributions from each vessel increase the NO concentrations in the tissue.  Note also 
that the peak concentrations in the endothelial segment closest to the other vessel are higher than 
the peak concentrations on the side farthest away from the other vessel. 
Figure 20C and 20D illustrate concentration profiles generated with unequal NO 
production rates in the arteriolar and venular endothelium for tissue thicknesses of 100 and 200 
82 
microns.  A tissue scavenging rate of 1.0 s-1 was assumed.  Note in both 20C and 20D, the 
bounded tissue concentrations are greater than the concentrations in the outer, unbounded tissue 
regions.  Consistent with results seen in Figures 19 and 20A-B, the vessel pairing acts to increase 
the peak endothelial NO concentrations in the regions adjacent to the bounded tissue region.   
8.4 Discussion 
For all arteriole-venule pair simulations, NO was shown to increase the area of oxygenated 
tissue above predicted levels for a single unpaired vessel.  This effect was observed for tissue 
thicknesses of 100 and 200 µm and the various NO scavenging rates described in the literature 
(Buerk, 2001).  This suggests that much greater tissue thicknesses would be required before 
vessel pairing effects do not contribute to increased tissue NO concentrations.   
In Figures 19 and 20, for equal maximum NO production rates, the concentrations 
generated by the arteriole were greater due to the increased O2 availability in this vessel.  When 
the peak concentrations in the two arteriolar or venular endothelium were compared, the peak 
concentrations closest to the bounded tissue region were greater than in the distal endothelial 
region. Similar findings were seen in Figure 20C and 20D, when unequal production rates were 
assumed in the arteriole and venule.  The increases in peak concentrations suggest that the 
arteriole is contributing to the increased concentration in the venular endothelium and the venule 
is contributing to the increased concentration in the arteriolar endothelium.  For the larger tissue 
thickness, similar findings were observed, however the differences in the peak endothelial 
concentrations were less than in the smaller tissue thickness. These findings suggest that single 
vessel models may only be valid in sparse vascular beds, such as the mesentery.  Future modeling 
studies to fully quantify these effects should include convective NO and O2 transport and 
coupling of multiple vessels in cylindrical geometry to enable downstream effects to be observed.   
Overall, these results suggest that future modeling studies should consider the discrete 
locations of the vessels with respect to neighboring vessels.  For NO transport, this could be an 
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important factor contributing to the NO concentrations available for reaction with sGC or other 
species in tissue.  This could also be used to explain the differences between experimentally 
reported arteriole and venule NO concentrations.  Some studies have suggested that venular NO 
concentrations are higher than NO concentrations (Mayer, 2000) while others assert that arteriolar 
concentrations are higher.  These effects are likely primarily due to convective effects, however if 
measurements were made in paired vessels, venular concentrations could be influenced by the 
arteriolar concentrations through diffusion in tissue.  The general results from this model illustrate 
that chemical transport in a section of tissue can be influenced by multiple vessels and should be 
considered in future models of NO transport.    
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Figure 18.  Model geometry used in paired arteriole-venule simulations.  A.  End view of cylindrical 
arteriole-venule pair.  The line along the centers  of the vessels corresponds to the layered structure used in 
the simulations in Cartesian coordinates.  B.  Representation of layered model structure in cartesian 
coordinates 
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Figure 19.  Comparison of NO concentration profiles in a segment of tissue for a tissue scavenging rate of 
7.5 s-1 and tissue thickness of 100 and 200 µm.  Long dashed lines represent center of vessel.  Dotted lines 
represent endothelium.
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igure 20.  Comparison of NO concentration profiles in a segment of tissue for a tissue scavenging rate of 
maximum NO production rates in the arteriolar and venular endothelium. 
B 
F
1.0 s-1 and tissue thickness of 100 and 200 µm.  Comparison of NO concentration profiles in a segment of 
tissue for a tissue scavenging rate of 1.0 s-1 and tissue thickness of 100 (C) and 200 µm (D) with different 
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Figure 20 (continued) 
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CHAPTER 9 : CELL RICH AND CELL FREE LAYERS 
 
 
9.1 Description 
This group of simulations compares concentration profiles generated by the model with 
and without a cell free region at a 45% systemic hematocrit.  The effects of different scavenging 
rates in tissue are also included.  For these simulations, the thickness of the cell free layer varied 
as a function of the hematocrit.  A medium sized arteriole 400 µm in length with an inner radius 
of 25 µm was simulated.  Other model layers include a 2.1 µm thick plasma layer, 2 µm thick 
endothelium, 9 µm thick vascular wall and 100 µm tissue thickness.  Different scavenging rates 
in tissue ranging from 0.01 s-1 to 10.0 s-1 were modeled to analyze the effect of these parameters 
on NO and O2 concentration profiles.   
9.2 Methods 
e general methodology and equations used for this group of simulations were the same 
as described in Chapters 5 - 6.  The only difference was the division of the vessel lumen into cell 
rich and cell free zones.  As described by Kavdia et al. (2001) and Sharan and Popel (2002), the 
width of the cell free layer is a function of the vessel diameter.  For these and subsequent 
simulations, the width of the cell free layer was determined as a function of the vessel diameter, 
based on data from Figure 4 in Sharan and Popel (2001).   
9.3 Results 
In Figures 21A – 21C, NO concentration profiles were generated from simulations both 
with and without the vessel lumen divided into cell rich and cell free zones for tissue scavenging 
rates ranging from 0.01 s-1 (21A) to 10.0 s-1 (21C).  Figure 21D compares the average wall NO 
oncentrations for different tissue scavenging rates. The scavenging rate in blood used for all 
imulations in Figure 21 was the same (382.5 s-1).  For simulations with the lumen divided into 
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two regions, sc l rich region.  
or this group of simulations, the hematocrit in the cell “rich” region was assumed to be slightly 
atocrit (46.5%) (Sharan and Popel, 2001).  To account for this, the 
scaveng
 
availability in the tissue region as seen in Figure 21E.   
2  
cture that includes cell rich and cell free regions. Kavdia 
nd Popel (2001) recently described the importance of simulating cell 
rich and cell free zones with thicknesses proportional to the systemic hematocrit.  In their model, 
inclusion of a cell-free plasma layer increased NO bioavailability in both blood and tissue, despite 
the high scavenging rate in blood used in their model.  The model described in this dissertation 
uses a much lower scavenging rate in blood based on scavenging rates for intact red blood cells 
(Table 1).  A wide range of tissue scavenging rates to evaluate the impact of these rates on model 
predictions.  The model findings are consistent with results presented by Kavdia et al. (2002) over 
the entire range of tissue scavenging rates simulated.  Incorporation of the cell-free layer more 
ndothelial NO concentration for the lowest NO scavenging rate in tissue.  
With a ls 
avenging of NO by hemoglobin was assumed to occur only in the cel
F
higher than the systemic hem
ing rate of NO by hemoglobin was adjusted proportionally to the slight increase in 
hematocrit.  Note that in Figures 21A-21D, inclusion of the cell free layer resulted in higher NO 
concentrations in both blood and tissue than in simulations without the cell free layer, particularly
for the lowest tissue scavenging rates.  Higher NO concentrations resulted in increased O2 
9.3.1 Discussion 
The mathematical model developed in this research project is the first to combine O -NO
interactions in a multilayered vessel stru
et al. (2002) and Sharan a
than doubled the peak e
 high scavenging rate, peak NO concentrations were still slightly elevated above the leve
generated without the cell-free layer.  These findings can be used as the basis for understanding 
NO production rates necessary to maintain vascular hemostasis.   
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Figure 21.  NO and PO2 profiles generated with and without a cell free re
-1 -1
No Cell free zone 
B 
gion for a systemic hematocrit of 
45% and different tissue scavenging rates (A) 0.01 s , (B) 1.0 s , and (C) 10.0 s-1.  Thick lines are from 
simulations with a cell free zone.  (D)  Average NO concentrations in the vascular wall with and without a 
cell free region.  (E)  Average PO2 values in tissue with and without a cell free region. 
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Figure 21 (continued) 
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Figure 21 (continued)   
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CHAPTER 10 : FÄHRAEUS EFFECT 
 
 
10.1 Description 
The model was expanded to include the well-known Fähraeus effect in addition to the 
cell free layer previously described, for systemic hematocrits of 22.5%, 45%, and 55%.  This 
group of simulations assumed a reduction in hematocrit and hemoglobin proportional to the 
vessel diameter.  The reduction in hematocrit decreased O2 availability for NO production and 
hemoglobin scavenging rates due the decrease in available hemoglobin.  Simulations were 
performed for different size arterioles ranging in diameter from 20 – 100 µm in diameter with 
lengths of 300 – 400 µm.  Tissue scavenging rates ranging from 0.01 s-1 to 10.0 s-1 were used in 
these simulations.  Additional factors affecting O2 availability and the resultant effects on NO 
roduction were also modeled.  Included in these simulations were reductions in hematocrit to 
mulate anemic supply deficit, decreases in O2 saturation to simulate hypoxic supply deficit, 
decreased pH, and increased CO2.    
10.2 Methods 
The general methods and equations used in this group of simulations were the same as 
those described in previous chapters.  However, previous simulations did not account for the 
reduction in hematocrit and associated blood O2 content due to the Fähraeus effect.  To account 
for this reduction, the hematocrit was reduced as described in Chapter 2 as a function of the 
vessel diameter and the data from Goldsmith et al.(1989) relating the ratio of HT / HD to vessel 
diameter.  Different vessel sizes and hematocrit values were simulated to determine the relative 
importance of the Fähraeus effect under different model conditions.  The simulations also 
incorporated changes in O2 saturation, pH, and CO2 using Equations 11 - 15 from Chapter 2.  The 
model parameters and dimensions used in these simulations can be found in Table 1. 
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10.3 Results 
In Figure 22, average wall NO concentrations and tissue O2 partial pressures were 
n with and without the Fähraeus effect.  Since a consensus in the 
literatur to 
 
es 
 and 
 
 
ote 
 due to the Fähraeus effect greatly decrease O2 availability 
in the tissue.   
 The Fähraeus effect becomes more significant in smaller vessels as seen in Figure 23.  In 
this fi  
ct 
for a particular size vessel and a tissue scavenging rate of 0.01 s .  Note the steep increase in NO 
availability in the vessel wall for vessel sizes of less than 30 m. 
 To more closely evaluate the impact of vessel size on NO availability, simulations 
incorporating the Fähraeus effect were run for a 20 µm diameter microvessel.  As seen in Figure 
24A, inclusion of the Fähraeus effect in a 20 µm vessel resulted in significant increases in 
average NO concentrations in the vascular wall region for the lowest reduction in hematocrit.  
Note, however, that the reduction in hematocrit to 79% of its systemic value only slightly 
compared for simulations ru
e has not been achieved regarding the amounts by which the hematocrit is reduced due 
the Fähraeus effect, the simulation results are reported for a range of reductions in hematocrit.
Goldsmith et al. (1989) showed that for a 50 µm arteriole, the hematocrit may be reduced by as 
little as 65% or may be as much as 86%, thus in Figures 22A and 22B, average NO and O2 valu
are compared with reductions in hematocrit to 86% of the systemic value and in Figures 22C
3D to 65% of the systemic hematocrit in the cell rich region.  As seen in Figures 22A and 22C,
for a 50 µm vessel, inclusion of the Fähraeus effect resulted in slightly higher NO concentrations
in the vascular wall and tissue than in simulations without the effect for the lowest tissue 
scavenging rate.  For a reduction to 86% of the systemic hematocrit value with high NO 
scavenging in tissue, inclusion of the Fähraeus effect had little effect on NO concentrations. N
that the reductions in tube hematocrit
gure, average NO concentrations in the vascular wall were compared for different vessel
sizes.  These simulations assumed the greatest reduction in hematocrit due to the Fähraeus effe
-1
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increased the average NO concentrations in the wall.  Also note in Figures 24B and 24D, the 
magni
n 
ns 
-1
ns.  The 
2 availability for NO production.  In Figure 27, the relative importance of these 
affecting O  availability, with the Fähraeus effect included in all simulations.  Note in this figure, 
the highest average wall NO concentrations were calculated when the hematocrit was 22.5%.  In 
this figure, the lowest concentrations NO occurred when the O  saturation was reduced to 50%.  
Changes in pCO2 resulted in slightly higher NO concentrations than changes in pH, however the 
magnitudes of these changes were slight compared to the changes observed during hypoxic or 
anemic O2 supply deficit. 
tude of the decreases in O2 availability due to the Fähraeus effect.   
 The effect of decreasing the hematocrit to simulate anemic supply deficit is depicted i
Figure 25.  In this figure, for a 20 µm arteriole, the systemic hematocrit was reduced to 22.5% 
and NO concentration profiles were compared with and without the Fähraeus effect.  Simulatio
assumed a reduction in core hematocrit to 50% or 79% of the systemic value and a tissue 
scavenging rate of 0.01 s .  Note in this figure that at a systemic hematocrit of 22.5% and a 50% 
reduction in systemic hematocrit value due to the Fähraeus effect, peak NO concentrations were 
three times the concentrations seen with 45% hematocrit and no Fähraeus effect.  The effect of 
increasing the systemic hematocrit to 55% is seen in Figure 26.  In this figure, increasing the 
hematocrit resulted in decreased NO concentration levels.   
 The reduction in tube hematocrit due to the Fähraeus effect has several implicatio
first implication, with regards to NO transport, is that NO scavenging will be reduced due to the 
decrease in hemoglobin levels.  The second implication is that the reduction in hematocrit will 
result in less O
two conflicting effects was compared.  In Figure 27A, the oxygen saturation was decreased to 
50% of its systemic value to simulate O2 supply deficit. Note in this figure, the highest NO 
concentrations were generated with the Fähraeus effect and in the absence of hypoxia.   
 Figure 27B compares the relative changes in NO concentrations for different conditions 
2
2
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A 
B 
A
Fähraeus Effect (0.86 * Hct) 
No Fähraeus Effect 
Figure 22.  Comparison of average NO concentrations and PO2 values with and without the Fähraeus Effec
PO2 values in tissue obtained from simulations with a reduction in hematocrit to 86% of its systemic valu
(C & D)  Average NO concentrations and PO  values obtained with a reduction in hematocrit to 65% of 
systemic value.   
t 
in the cell rich region for a 50 micron arteriole.  (A & B).  Average NO concentrations in vascular wall and 
e.  
2 its 
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Fähraeus Effect (0.65 * Hct) 
No Fähraeus Effect 
C 
D 
Figure 22 (continued)     
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Fi 3.  Comparison of peak NO concentrations generated in the endothelium as a function of vessel 
d r.  For these simulations, the width of the cell free region was specified as a function of the vessel 
diameter.  Within the cell rich region, the hematocrit was reduced by the Fähraeus effect.   
gure 2
iamete
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A
B 
Figure 24. Comparison of average NO concentrations and PO2 values with and without the Fähraeus Effect 
in the cell free region for a 20 micron arteriole.  (A & B)  Average NO concentrations in vascular wall and 
PO2 profiles in tissue obtained with a reduction in hematocrit to 50% of its systemic value.  (C & D)  NO 
concentrations and PO2 values obtained with a reduction in hematocrit to 79% of its systemic value.   
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C
D
Figure 24 (continued)  
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Figure 25.  Comparison of NO profiles at 22.5% hematocrit and 45% hematocrit with and without the 
Fähraeus Effect for a 20 micron arteriole.  Scavenging constants and blood O2 concentrations are adjusted 
to account for the reduction in hematocrit.   
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Fi
se 
gure 26.  Comparison of NO profiles at 55% hematocrit and 45% hematocrit with and without the 
Fähraeus Effect for a 20 micron arteriole.  Scavenging constants were adjusted to account for the increa
in hematocrit.   
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Figure 27.  Effect of O2 availability on NO concentration profiles. (A) Comparison of NO profiles with and 
without hypoxic O2 supply deficit (Saturation = 0.5 * Saturation).  Simulations were run with and without 
the Fahraues Effect at 45% hematocrit.  (B)  Impact of various factors affecting O2 delivery on NO 
profiles.  All simulations include the Fähraeus Effect at 0.5 * Hct and cell rich and cell free zones.  The 
baseline case refers to a case with 45% hematocrit, pH = 7.4, pCO2 = 40 mmHg, and cell rich and cell free 
zones.    
 
A 
B 
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10.3.1   Discussion 
Numerous modeling studies have included the Fähraeus effect in the microcirculation 
(Ye et al., 1998, Pries et al., 1986, Sharan and Popel, 2001), however, this effect has not been 
included in NO biotransport modeling studies to date.  As described by Ye et al. (1998), inclusion 
of the Fähraeus effect in O2-CO2 transport models is important and should not be neglected.  This 
research study extends this observation for models of NO transport, particularly for vessels less 
than 30 µm in diameter.  For a 50 µm vessel, inclusion of the Fähraeus effect slightly increased 
average NO concentrations in the vascular wall for the lowest tissue scavenging rate (Figures 22A 
and 22C).  However, in a 20 µm vessel, average NO concentrations in the wall were significantly 
increased (Figures 24A and 24C).  Two factors that contribute to the increasing importance of the 
Fähraeus effect in small diameter vessels are the variation in the thickness of the cell free layer as 
a function of vessel diameter (Bugliarello and Sevilla, 1970, Sharan and Popel, 2001) and 
changes in the ratio of HT / HD as a function of vessel diameter.  As shown by Sharan and Popel 
(2001), the plasma layer thickness is highest in 50 µm diameter vessels for systemic hematocrit 
values ranging from 20 to 60%.  Goldsmith et al. (1989) illustrated that the ratio of HT / HD is 
lowest in vessels ranging from approximately 12- 18 µm in diameter.  In the current simulations, 
the combined effects of these two factors suggests that with regards to NO transport, the Fähraeus 
effect is most important in vessels less than 30 µm in diameter. 
Inclusion of the Fähraeus effect in the simulations resulted in higher concentrations of 
NO in the vascular wall as seen in Figure 24.  Early studies suggested that NO concentrations of 
~250 nM (Stone and Marletta, 1996) are required to induce vasodilation, however, more recent 
tion 
hus the model can be used to better understand the range of NO production rates associated with 
studies suggest that the levels may be much lower than previously thought (<100 nM) (Condorelli 
and George, 2001).    By including the Fähraeus effect in the simulations, lower NO produc
rates are needed to generate wall NO concentrations sufficient to induce vasodilatory effects.  
T
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vasodilatory function.  As seen in Figure 25, for low hematocrits in small vessels, inclusion of the 
Fähraeus effect greatly increased the NO concentrations delivered to the vascular wall.  As 
expecte l. 
(2002) illustrated the importance of including the cell free layer in mathematical models of NO 
transport for analysis of blood substitutes.  They concluded that hemoglobin-based oxygen 
NO concentrations influencing sGC thus suppressing vasoactive effects.  Inclusion of the 
Fähraeus effect may also be an important factor to consider when modeling HBOCs since much 
lower NO production rates would be needed to induce vasodilatory effects.  Inclusion of the 
by sGC to levels at which vasoactivity would occur.  Neglecting the Fähraeus effect could 
underestimate the NO concentrations that may be present in the vascular wall.    
f 
plasma, the efficiency of O2 and CO2 exchange is decreased.  As illustrated in Figures 22B, 22D, 
2
2 tal 
odeling studies by Ye et al. 
(1998) 
 
t 
 to 
d, in contrast, elevating the hematocrit reduced NO availability (Figure 26).  Kavdia et a
carriers (HBOCs), with scavenging rates similar to those found in vivo, could effectively reduce 
Fähraeus effect in smaller vessels at a low hematocrit could elevate the NO concentrations seen 
The Fähraeus effect implies that, due to the higher velocities of the red cells than o
24B, and 24D, inclusion of the Fähraeus effect decreases O  availability in distal tissue regions 
due to this decreased efficiency in gas exchange.  The highest O  concentrations seen in the dis
tissue regions occurred for the simulations without the Fähraeus effect.  The lowest 
concentrations seen in the distal region occurred for simulations with the Fähraeus effect and no 
interactions between NO and O2 (results not shown).  Previous m
did not account for interactions between NO and O2 in the tissue region.  The current 
simulations predict higher levels in the tissue than the modeling studies by Ye et al. (1998) due to
the inhibition of O2 consumption by NO. However, the inhibition of O2 metabolism by NO is no
significant enough to overcome the decreases in oxygenation due to the Fähraeus effect.   
Changes in hematocrit due to the Fähraeus effect can lead to seemingly contradictory 
effects.  Figures 22 - 24 suggest that increased NO concentrations in blood and tissue occur due
the Fähraeus effect.  However, oxygen availability is also reduced due the Fähraeus effect thus 
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NO production is decreased due to decreased blood oxygen levels.  In Figure 27, different factors 
contributing to decreased oxygen saturation, including pH, pCO2, and hypoxia, were simula
determine the effects on NO production and NO profiles.  Reducing the O2 availability by one-
half decreased the peak endothelial concentration by ~20 nM.  However, the increase in NO due
to the reduced scavenging by hemoglobin was ~40 nM.  Comparing the magnitude of these 
effects suggests that the reductions in hematocrit due to the Fähraeus effect are the dominant 
effect over reductions in O2 available for NO production.  Based on Km values presented in
literature (Rengasamy and Johns, 1986, Buerk, 2001) and simulation results obtained using the 
model presented in this dissertation, eNOS is relatively insensitive to changes in O2.  Since N
production from eNOS is relatively insensitive to O2 changes, one would expect the reduction in
hematocrit due to the Fähraeus effect to be the dominant effect.  The modeling confirms thi
hypothesis for eNOS.  However, for other NOS isoforms that are more highly O2
ted to 
 
 the 
O 
 
s 
-dependent, such 
as nNO
h O2 
his 
 
S, the Fähraeus effect may become less dominant. 
 Figure 27B provides a comparison of different factors affecting NO production and 
transport.  Previous figures showed that anemic and hypoxic O2 supply deficit can greatly 
influence NO bioavailability.  As seen in this figure, while factors such as pH and pCO2 can also 
influence O2 saturation, these factors do not significantly affect NO transport throug
dependent mechanisms.  Decreases in pH to 6.2 or increases in CO2 to 100 Torr slightly elevated 
the peak NO concentrations generated due to the shifting of the oxyhemoglobin curve and 
increased oxygen availability, however, the magnitude of these effects was relatively small.  T
suggests that any reported changes in NO production due to pH or pCO2 are independent of the 
reactions of eNOS with O2.   
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CHAPTER 11  : DYNAMIC SIMULATIONS 
 
11.1 Description 
Under physiological conditions, the interactions between NO and O in the 
microcirculation are dynamic processes, thus it is important for the mathematical model to be
dynamic in nature and include time-varying effects.  The next group of simulations were 
developed to provide the framework for future simulations involving time-dependent changes in
NO production and transport.  Initial simulations were performed as a proof of concept.  In these
simulations, a step change in NO concentration was imposed and NO diffusion into tissue was 
calculated.  Interactive effects between O  and NO were included in the simulations.  The step 
change in NO production is similar to that modeled by Shrager et al (1998).  For these 
simulations convective effects were neglected and diffusion was assumed to occur only in the 
radial direction. 
 
2 
 
 
 
2
ue. 
model 
11.3 Results 
Figure 28 shows NO and O2 concentration profiles at different time increments. Note that 
NO concentrations reached steady state at ~2.7 msec while O2 concentrations reached steady state 
at ~ 20 msec.   
11.2 Methods 
The general simulation methods used were the same as described in Chapters 5 and 6 for 
simulations with O2-dependent NO production and interactions between NO and O2 in tiss
Time-dependent contributions were included by keeping the dCi/dt terms in Eqn. 8.  A step 
change in NO concentration from 100 to 125 µm was assumed to occur at t = 2 msec.  The 
was run for various time steps to verify grid independence.    
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11.4 Discussion 
Inclusion of time dependent NO transport properties is of critical importance in models of 
 its derivatives rapidly react with other chemical species and are 
rapidly  with 
 
 elastic 
ce 
ies 
 
ight not be observed at steady state.  This illustrates the need to include time-
dependence in the simulations.  For the simple case simulated, the time differences to achieve 
steady state were slight, however with multiple chemical species these effects could become more 
significant.   
NO transport since NO and
transported in the microcirculation.  In addition, systemic changes associated
changes in NO are time-dependent.  For example, changes in vessel diameter due to changes in
shear stress have an associated time constant due to the dynamic nature of blood flow and
properties of the vessel.   
The results from these simulations show that following a step change in NO concentration, 
NO and O2 concentrations increase progressively over time until a new steady state is reached.  
The time for O2 to reach steady state was longer than the time for NO to reach steady state.  Sin
NO and O2 transport are inherently coupled in the microcirculation, changes in one spec
concentration at a particular point in time could lead to dynamic effects, such as changes in NO
production, that m
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 Figure 28.  Comparison of NO and O2 profiles following a step change in NO production at t = 2 msec. 
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CHAPTER 12 : NO AND VESSEL DIAMETER CHANGES IN RESPONSE TO 
CHANGES IN SHEAR STRESS 
 
12.1 Description 
A pilot model was developed that incorporated dynamic changes in arteriolar diameter and 
NO coupled with changes in wall shear stress.  Changes in vessel diameter and NO production 
were computed in response to a step change in flow.  Changes in vessel diameter were based on 
experimental data obtained by Sun et al. (1997) from in vitro isolated arterioles.  In the 
experiments by Sun et al. (1997), vessel diameter changes in response to wall shear stress were 
measured following a step change in flow.  Changes in NO concentration were based on data 
from Mashour and Boock (1999).  Simulations were performed for a 72 µm diameter arteriole 
and assumed an increase in blood flow from 0 to 7 ml/min.   
12.2 Methods 
The general transport equation used to model NO and O2 transport was Eqn. 8.  The model 
assumed NO and O2 interactions in tissue and a fixed NO concentration in the endothelium.  The 
blood flow was assumed to be a Poisseuille flow.  Elastic properties of the vessel were neglected 
and the changes in diameter were assumed to occur nearly instantaneously over a fixed time 
interval.  Wall shear stresses were calculated using Eqns. 5 - 7.   
At t = 2 msec, a change in flow was assumed to occur.  Following the step change in flow, 
the flow rate was held constant.  Pressure was also assumed to remain constant.  The step change 
in flow was modeled in FlexPDE as a tight sigmoid for computational stability.  Following the 
increase in flow, wall shear stress values were computed and the associated diameter change 
calculated using the non-linear relationship between wall shear stress and vessel diameter 
presented by Sun et al. (1997).  The diameter change was assumed to occur over a short time 
interval, 7 msec.  Note the time modeled for the vessel diameter change to occur is lower than 
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w
roperties of the vascular wall, the overall shapes of the curves seen in Figure 29 would not 
change if the diameter changes were assumed to occur over a longer time interval.  The new 
vessel diameter was then used to calculate new shear stress values and the procedure repeated 
until t
 NO 
  
be 
in NO concentration since it depicts 
changes in response to shear stress over 8 – 24 hours.  However, it was used as a rough 
approximation to understand generally how NO might be expected to change. 
evated above the initial 
conce
12.4 Discussion 
ar 
ges 
ar 
ould be expected to occur in vivo.  However, since the model did not explicitly include elastic 
p
he diameter changes reduced the shear stress to a new steady state level.  Relaxation was 
assumed to occur instantaneously due to the inelastic nature of the vessel walls. 
NO was assumed to increase linearly in proportion to the changes in shear stress using in 
vitro data from Mashour and Boock (1999).  Currently there is a shortage of data relating
concentrations, shear stress, and vessel diameter (Mashour and Boock, 1999; Kelm et al., 1991).
The study by Mashour and Boock (1999) represents one of few studies in the literature that 
measured changes in NO concentration as a function of shear stress.  The in vitro data may not 
an accurate representation of the magnitude of acute changes 
12.3 Results 
Figure 29 illustrates how blood flow, wall shear stress, vessel diameter, and NO would be 
expected to change over time following an increase in blood flow.  The changes in NO 
concentration represent the amount the concentration would be el
ntration (100 nM).  Note in this figure that the changes in vessel diameter do not reduce the 
wall shear stress levels to the initial levels prior to the change in flow. 
As can be seen in Figure 29, changes in vessel diameter helped reduce the wall she
stress.  Since the blood flow was assumed to be held at a constant flow rate and pressure, chan
in diameter were the only means by which the system could compensate for the increases in she
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stress and reach a new steady state level.  The new steady state wall shear stress level was slightly
higher than the initial shear stress level.  These results are similar to findings by Mashour and
Boock (1999) in which shear stress levels were reduced, but reached a steady state shear stres
level higher than the original shear stress level.  To understand the relative contributions of 
multiple factors in a complete system model, it is necessary to fix the values of some parameters
These simulations do not incorporate all of the factors that would normally be pr
 
 
s 
.  
esent in vivo, 
such a e 
anges in 
s in flow and 
pressure would need to be incorporated along with the elastic properties of the vessel.  However, 
more experimental data are needed to fully develop the model.  There is limited data available in 
the literature relating NO, shear stress, and vessel diameter.  Experiments that could establish this 
relationship would provide useful data that could be used to develop a mathematical model to 
predict the adaptive response of vessels in vivo to changes in shear stress or NO production.  This 
therapeutics. 
s elastic wall properties, dynamic pressure changes, or dynamic flow changes, however, th
simulations provide a preliminary method for predicting how diameter changes contribute to 
vascular hemostasis and the relative contribution of this mechanism.  Future simulations would 
require fixing the flow parameters and the elastic parameters individually to ascertain the 
importance of these factors during transient vessel changes. 
The general methodology used in these simulations provides the framework to develop 
future simulations that incorporate dynamic changes in vessel diameter in response to ch
shear stress and NO concentration.  To fully model the system dynamic change
holds great potential for understanding disease processes and predicting the effects of clinical 
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Figure 29.  Dynamic changes in wall shear stress, vessel diameter, and NO concentration following an
increase in blood flow.   
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CHAPTER 13 : ADDITIONAL CHEMICAL REACTIONS 
 
 
13.1 Description 
The mathematical model was expanded to include additional chemical species in the 
simulations.  Chemical reactions and diffusion were modeled for NO, O2, superoxide, 
peroxynitrite, nitrate, and nitrite in a 50 µm diameter vessel to examine the effects of superoxide 
on NO concentration profiles.  Excessive superoxide production has been implicated in numerous 
clinical conditions.  Reaction times between chemical species were assumed to occur rapidly thus 
convective transport was neglected.  The simulation methodology was used as the basis for 
additional work that studied how different superoxide and superoxide dismutase concentrations 
influence NO transport (Buerk et al., 2003).   
13.2 Methods 
The general equation used as the basis for these simulations was 
∑±∇⋅−∇=∂∂ → n iiiii RCvCDt
C 2        (46) 
Due to the dynamic nature of the chemical reactions, the time-dependent term was included.  The 
simulations were run using time increments (dt) of 0.01 msec.  Interactive transport equations 
were included for the different species (i in Eqn. 8 ):  O2, NO, superoxide (O2•-), peroxynitrite 
(ONOO-), nitrite (NO2-), and nitrate NO3-.  Numerous other species also react with the modeled 
species, such as hydrogen peroxide or thiols, but were not included in these simulations to limit 
the number of mass balance equations.  Reactions with hydrogen peroxide were included in the 
model by Buerk et al. (2003).  The reaction terms included in the transport equation for each 
species were determined as a function of the chemical reactions and associated mass balances due 
to reactions with other species.  The equations used for each species were: 
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The specific values for the parameters used in the model can be found in Table 4.  Superoxide 
production was assumed to occur at a fixed rat
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e in the vascular wall and/or endothelium although 
it can be modeled explicitly using Michaelis-Menten kinetics (Buerk, 2001).  Peroxynitrite was 
assumed to be generated from the reaction between NO and O2•-.  This reaction was assumed to 
occur in all modeled layers.  Peroxynitrite was assumed to be “consumed” through reactions with 
NO and CO2 or through spontaneous d
profiles were not calculated explicitly, but specified as a model input.  CO2 transport should be 
added in future model revisions since it also affects O2 transport. 
O2-dependent NO production as well as interactions between NO and O2 in tissue were 
included.  Simulations were run over time until a pseudo-steady state was reached. The 
simulations were run using dt values of 0.01.  Tests were performed at different dt values to 
verify that the model results were independent of the simulation time steps chosen.  The mass 
balances for NO2- and NO3- did not include all possible biochemical reactions and production of 
these species was assumed to be dependent only on the other species included in the model.   As 
described by Buerk et al. (2003), the mass balances would not be expected to reach a true steady 
state since convective transport or all of the biochemical reactions were not included.    
ecomposition to ONOOH.   Note that CO2 concentration 
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Table 4.  Parameters Used in Simulations Involving Multiple Chemical Species 
 
DEFINITION    VALUE(S)  
  
l Geometry 
 
 Vessel Length   400.0 µm (Ye et al., 1994) 
 
ssel Diameter   50.0 µm
 
Plasma Layer Thickness  2.0 µm  (Sharan and Popel, 2001) 
 
Endothelium   2.0 µm  (Buerk, 2001) 
Vascular Wall   9.0 µm  (Vadapalli et al, 2000) 
 
Tissue Thickness   100.0 µm (Vaughn et al., 1998; Butler, 1998) 
Hematocrit    45% 
Solubility Coefficient   1.3 µM Torr-1 (Buerk, 2001) 
Diffusion Coefficients 
 O2     2.8 x 10-5 cm2 s-1 (Ye et al., 1994) 
 NO     3.3 x 10  cm  s  (Buerk, 2001) 
 O2      2.8 x 10  cm  s  (Ye et al., 1994) 
 ONOO-    2.6 x 10  cm  s  (Chen and Deen, 2001) 
Maximum O2 Consumption (QMax)  
 
Vascular wall   5.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
Tissue    50.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
Hemoglobin Scavenging (k1) of NO 95.6 s-1 - 382.5 s-1 (Carlson and Comroe, 1958)  
 of ONOO- (k5)   30 s-1   (Savill et al., 2002) 
Tissue Scavenging (k1)   0.01 s-1 – 10.0 s-1 (Vaughn et al., 1998,  
Km 
 eNOS    4.7 Torr  (Rengasamy & Johns, 1996) 
 
Vesse
Ve  (Ye et al., 1994) 
 
 
 
 
 
 
-5 2 -1
 
•- -5 2 -1
 
-5 2 -1
 
 
 
 
 
          Thomas et al., 2001) 
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Reaction Coefficients (k)  
 
Auto-oxidation (k )  9.2 x 106 M -2 s -1  (Lewis and Deen, 
ide with NO (k3) 6.7 x 10
9
 M-1 s-1  (Huie and 
3) 
4 (Pfeiffer 
t al., 1997) 
Peroxynitrite with CO2 (k7) 2.9 x 10 M s-1  (Chen and Deen, 2001) 
Peroxynitrite decomposition (k6) 4.5 s-1  (Chen and Deen, 2001) 
2
1994) 
 
Superox
admaja, 199P
 
Peroxynitrite with NO (k ) 9.1 x 104 M-1s-1  
e
 
4 -1
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13.3 Results 
re 30 contains predicted concentration profiles for all of the modeled chemical species 
g rate of 0.01 s  and a O2 production rate 0.1 µM s .   These plots were 
generate d steady state.
the peak ns a an in re us 
simulati -1 ide elium, 
vascular wall, and tissue.  The presence of multiple production locations for superoxide yield the 
increasing concentrations observed in the outward radial direction.    Scavenging of NO2-, NO3-, 
and ONOO- by O2•- yields the decreasing concentrations seen in the tissue segment.     
Figure 31 compares NO concentration profiles both with and without the presence of O2•- 
and other chemical species in the simulations.  Both simulations assumed a tissue scavenging rate 
of 0.01 s-1 (solid lines).  A concentration profile with a scavenging rate of 7.5 s-1 is also included 
for comparison purposes (dashed line).   As seen in this figure, inclusion of O2•-and other 
chemical species significantly decreases the peak endothelial NO concentration.   
Figure 32 compares NO and O2 profiles for different O2•- production rates ranging from 
0.01 to 0.1 µM s-1.  As seen in this figure, decreasing the production of O2•- increases the 
concentration of NO.  This in turn also helps to increase O2 concentrations delivered to distal 
tissue regions through interactions with NO as seen in 32B.   
13.4 Discussion 
Excessive O2•- production has been implicated in a number of disease states including 
hypercholesterolemia, atherosclerosis, hypertension, and diabetes mellitus (Loscalzo and Vita, 
2000).  Studies have shown that levels of ambient levels of vascular O2•- play an important role in 
affecting NO bioactivity during these pathological states, although the sources of O2•- are not yet 
well defined.  Studies also suggest that O2•- may help to modulate NO activity under normal 
Figu
with a tissue scavengin -1 •- -1
d at a simulation time of 9 msec after the model had reache   In this figure, 
 endothelial NO concentratio re much lower th sults presented in previo
ons with a tissue scavenging rate of 0.01 s .  Superox  is produced in the endoth
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physiological conditions (Loscalzo and Vita, 2000).  Based on the simulation results shown in 
Figures 30 - 32, scavenging of NO by O2•- is a significant process that greatly reduces the amount 
of NO available for reaction with sGC.  This contributes to a decreased level of O2 in the distal 
tissue regions.  In addition, scavenging by O2 decreases the amounts of NO2 , NO3 , and ONOO
in the endothelium, vascular wall, and tissue.   Decreases in ONOO  are significant since this 
species also contributes to activation of sGC, although much less than NO.  The reductions in NO 
and ONOO  could contribute to the increases in blood pressure associated with several disease 
states, although other mechanisms most likely contribute as well.   
 Introducing superoxide dismutase into the simulations would be expected to increase NO 
bioavailability since it acts to effectively scavenge O2 .  Results from Buerk et al. (2003) confirm 
this finding.  The model could be expanded to include the presence of SOD under normal 
conditions to help protect against constitutive O2 production or O2  production that occurs from 
normal oxidative metabolism (Stralin et al., 1995).  The model could also be expanded to include 
higher concentrations of SOD to compensate for higher levels of O2 production.  This could 
have potential for development of clinical therapeutics in early disease states, although studies 
have shown that advanced disease states are largely insensitive to SOD (Loscalzo and Panza, 
2
scavenging rate of 0.01 s  more closely represented profiles generated with much higher tissue 
1).  This suggests that the higher scavenging rates reported in some 
studies may include the reactions of NO with additional chemical species.  This could help 
explain the variability in reported tissue scavenging rates. 
Scavenging of NO by O2•- can greatly reduce NO concentrations to levels insufficient to 
fully activate sGC.  While these findings have been confirmed using experimental and 
mathematical models, O2•- production rates have not yet been quantified.  As seen in Figure 32, 
•- - - - 
-
-
•-
•- •-
•- 
2000, White et al., 1994). 
 With scavenging of NO by O •-, the NO concentration profiles generated for a tissue 
-1
scavenging rates (Figure 3
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slight differences in O2•- production rates had significantly different effects on the peak 
endothelial NO concentrations.  For low O2•- production rates, NO concentration profiles were 
much less affected although at even seemingly low production rates, the peak endothelial NO 
concentration was still reduced.   Further modeling studies, in conjunction with experimentation 
may be used to help elucidate these rates. 
Overall these model results suggest that in vivo NO concentrations may be less than those 
predicted in vitro due to the presence of additional chemical species.  By including additional 
chemical species in the mathematical model, the relative importance of these species on NO 
transport can be more accurately determined.  Inclusion of additional chemical species in NO 
transport modeling more closely represents in vivo conditions and should provide valuable insight 
into the mechanisms contributing to normal and impaired vasodilatory functions.   
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Figure 30.  Comparison of concentration profiles for multiple chemical species with a superoxide 
production rate of 0.01 µM s-1.   
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Figure 31.  Comparison of NO profiles with and without superoxide production.  Lowest line represents 
case with superoxide production.  No production of superoxide is assumed in other two cases. 
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Figure 32.  Comparison of NO and O2 concentration profiles with different production rates of superoxide.  
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CHAPTER 14 : CONVECTIVE TRANSPORT  
 
 
14.1 Description 
 Once the general radial mass transport properties were established, the model was 
expanded to include convective transport.  This group of simulations considered an arteriole 35 
µm in diameter, 400 µm in length.  Transport was assumed to occur only in the z-direction, thus 
only advective contributions were included.  Axial diffusion was also included for completeness 
since it did not significantly increase the complexity of the simulations or simulation times.  O2 
was assumed to enter the vessel along the inlet boundary of the vessel lumen.  Both bound and 
dissolved O2 in the vessel lumen were included.  Simulations were performed for different inlet 
O2 conditions, blood velocities and different NO production rates.  All simulations included O2-
dependent NO production and NO and O2 interactions in tissue.  
14.2 Methods 
Convective transport was included in the simulations by including the second term on the 
right hand side of the general steady diffusion-reaction equation 
        (43) 
For advective transport in the z-direction, Eqn. 43 reduces to 
  
∑±∇⋅−∇= →
n
iiii RCvCD
20
∑±−∇=
n
i
i
ii Rdz
dCvCD 20       (44) 
The velocity profile used in the simulations was calculated using the equation previously 
described for a rigid cylindrical tube (Eqn. 18).    The convective transport simulations included 
O2-dependent NO production and NO-O2 interactions in the tissue.  Modeled layers included cell 
ch and cell free layers as well as the vascular wall.   ri
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 One addition ified O2 
oncentration enters the vessel at the vessel inlet (z = 0) such that 
al boundary condition added to the model assumes a spec
c
   OC inletz C==02        (45) 
here C as 
2 2
.  
l 
w inlet is a specified O2 concentration.  For these simulations, the inlet concentration w
assumed to range from 40 – 80 µM.  To reduce computational instabilities associated with 
modeling the inlet O  as a plug flow, the O  entering the vessel was also modeled as a parabolic 
flow.  Figure 35 compares axial O2 concentration profiles modeled using parabolic versus plug 
flow inlet conditions.    
O2 in the bloodstream was assumed to consist of both bound and dissolved components
Without the bound component of O2, O2 concentrations were rapidly scavenging along the vesse
yielding nearly zero concentrations at the vessel outlet.  To account for the dissolved and bound 
components, Eqn. 44 becomes  
02
2
=−


 +− Q
dz
dS*Hct*
dz
)C*(d
vC* OO β
α
  2∇D α   (46) 
where S represents O2 saturation obtained from the oxyhemoglobin dissociation curve.  In the 
simulations S was calculated using the modified Easton’s equation from Chapter 2.  The specific 
model parameters and vessel dimensions used ca
solved in dimensionless forms for 
both modeled species, NO and O2.  To put the equations into dimensionless forms, the following 
dimensionless variables were defined: 
n be found in Table 5.   
 For computational stability in FlexPDE, Eqn. 44 was 
 
fRe
NO* CNO =      
fRe
O* CC 2= ;     
fRe
* rr = ;     zz* = ;        
where the asterisks denote dimensionless variables, the subscript Ref denotes a specified 
reference concentration or a specified radial distance, a
(47) 
nd L corresponds to the vessel length.    
 For NO, when expanded, Eqn. 44 becomes 
NO C R L
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simulated.  Substituting the dimensionless variables yields 
In Eqn. 48, λ represents the scavenging rate in tissue or in blood depending on the model layer 
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RNO was also made dime
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 For O , Eqn. 46 becomes 
       (50) 
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where Q is the metabolic rate of tissue.  From the chain rule for derivatives,  
CSS ∂∂∂
zCz ∂∂=∂         (52) 
In dimensionless terms, Eqn. 51 becomes 
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Rearranging yields 
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In Eqn. 54, the quantity v dC*/dz* represents the Peclet number.  The term is obtained 
by taking the derivative of the dimensionless Easton equation.  The metabolic rate was also made 
dimensionless where 
*C/S ∂∂
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14.3 Results 
Figure 33 shows NO and O2 concentration profiles in the vessel and surrounding wall and 
 simulations.  R and z in Figures 33A and 33B are 
nsionless length scale. 
represent the boundaries between the modeled layers (lumen, plasma layer, endothelium, vascular 
tration gradient at the inner surface of the endothelium is 
shown in Figure 33C.  The axial O2 gradients at the center of the vessel and at the inner surface of 
the endothelium are shown in Figure 33D.  In contrast to previous simulations, differences in O2 
ium due to the 
parabolic velocity profile.  In Figures 33A and 33B, the lowest species concentrations are seen at 
the end of the vessel in the outermost tissue region, however O2 concentrations do not reach zero 
in this region.   
The effects of including a parabolic inlet boundary condition for O2 are shown in Figure 
34.  Concentration profiles with and without the parabolic inlet condition are compared.  Note the 
ape of the contours particularly near the vessel inlet. 
Simulations were run for three different inlet O2 concentrations (35, 44.1, and 60 µM) as 
seen in Figure 35.  The inlet concentration of 44.1 µM (Figure 35A) corresponds to experimental 
eter.  Fi
.  In these figures, the value associated with the outermost contour in the 
tissue obtained from the convective transport
plotted on a dime  In the contour plots, the solid, black horizontal lines 
wall, tissue). The axial NO concen
concentrations are observed between the center of the vessel and the endothel
differences in the sh
data reported by Vadapalli et al. (2000) for a vessel 35 microns in diam gures 35B and 
35C illustrate how O2 delivery to tissue would change as the inlet O2 availability decreases or 
increases, respectively
128 
distal tissue regions increases or decreases as the inlet O2 concentration increases or decreases, 
however the general shape of the contours remains constant between Figures 35A-35C. 
Figure 36 illustrates the O2 concentration contour plot generated without interactions 
between NO and O2 in tissue.  In these simulations a fixed metabolic rate was assumed that was 
75% of the maximum metabolic rate assumed in previous simulations.  Tissue O2 concentrations 
fall to zero in the distal tissue regions even with a decreased maximum metabolic rate. 
pares O2 concentration gradients for different blood velocities. Figure 37A 
shows t
ts 
2 ote 
f the 
NOMax
decrease from the 30 µM s-1 maximum production rate assumed in Figure 38B.  For decreased 
NO production, observe that the concentrations in the distal tissue region at the end of the vessel 
are decreased and the general contour shape is altered in the outer tissue region.  Figure 38C 
contains the NO concentration countour.  Note in this figure the decreases in the outer tissue 
regions. 
al., 
 
Figure 37 com
he O2 concentration contour for a maximum blood velocity of 2800 µm s-1 while Figure 
37B shows the O2 concentration contour for a maximum velocity of 3200 µm s-1.  Note the effec
of velocity on the O  concentrations in the outer tissue regions at the end of the vessel.  Also n
the general change in the contour shape between the 37A and 37B, particularly in the outer tissue 
region near the end of the vessel.  The maximum NO concentrations, particularly at the end o
vessel, are not significantly different from between Figure 37C and Figure 33A for the modeled 
decrease in blood velocity.  At the end of the vessel, the peak endothelial NO concentration is 
~128 nM for the higher velocity and ~127 nM for the lower velocity. 
The effects of different NO production rates on O2 delivery to tissue were compared in 
Figure 38A, a maximum production rate (R ) of 25 µM s-1 was assumed.  This rate is a 
14.4 Discussion 
Convective transport properties have shown to be of importance in O2 transport (Ye et 
1994; Beard and Bassingthwaite, 2001).  Convective transport was hypothesized to be important
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in NO transport models at the onset of this study due to the inherent interactions in the 
microcirculation between these species.  Results from the study confirm this hypothesis and 
illustrat t is 
nal 
limitatio
ic 
entration while the peak O2 
concent
d 
 If 
ld 
on-uniform vasodilation along the vessel.  The relative constancy in average 
concentrations suggests that axial gradients could contribute to uniform vasodilation. 
 affect O2 concentration gradients, particularly in the distal tissue 
regions 
e several important factors affecting NO and O2 biotransport when convective transpor
included, particularly with regards to O2 transport. 
 NO biotransport was shown to be significantly affected by decreases in NO production, 
but only minimally affected by the modeled changes in velocity.  However, computatio
ns prevented a wider range of velocities to be simulated to fully quantify the effects of 
changes in velocity.  Future work should involve increasing the computational stability of the 
model and simulations of a wider range of velocities.  The computational instabilities resulted in 
the oscillatory fluctuations in NO concentration seen along the edge of the vessel lumen.  Despite 
these fluctuations, however, the general transport properties in the endothelium and tissue were 
quantified.  As seen in Figure 33C, the influx of O2 yields a sharp initial increase in NO 
concentration followed by a gradual decrease in concentration in the axial direction.  The sharp 
increase is due to the instantaneous or step increase in O2 at the inlet of the vessel.  The parabol
shape of the inlet O2 curve affects the slope of the increase in NO conc
ration affects the magnitude of the increase in NO concentration.   
 The decreases in NO concentrations in the axial direction between the vessel inlet an
outlet were approximately 10 nM, approximately a 7% decrease in NO concentration in Figure 
33C.  These slight differences in axial concentrations between the vessel inlet and outlet yielded 
relatively constant average concentrations in the vascular wall along the length of the vessel. 
significant differences in average wall concentrations along the vessel were observed this cou
suggest n
 NO was shown to
at the end of the vessel.  The changes in O2 concentration are due to the effects of NO on 
O2 metabolism described in previous chapters.  For decreases in NO production, the O2 delivered 
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to the outer tissue region at the end of the vessel was significantly affected.  Decreasing
production rate increased the curvature of the O2 contours in Figure 45A.  The increases in 
curvature resulted in larger decreases in O2 availability
 the NO 
 in the distal tissue regions at the vessel outlet, 
d 
 
 
f the tissue region.  
or a m  
 
 O2 
 enhance 
2 deliv
 in the outer tissue region at the end of the 
vessel.  The magnitude of these effects, particularly
provides further evidence that NO may act as a protective mechanism to enhance O2 delivery to 
tissue. 
The O2 gradient in the axial direction was shown to decrease and is affected by the bloo
velocity, systemic hematocrit, and the NO-dependent tissue metabolic rate.  Inclusion of bound
and dissolved O2 components was an important factor contributing the O2 concentrations in the 
vessel.  When bound O2 was not included, O2 concentrations fell rapidly to zero in the axial 
direction.  Decreases in blood velocity did not significantly affect NO concentration profiles, but
did affect the shape of the concentration contours for O2.  In contrast, changing the inlet 
concentration of O2 did not affect the shape of the contours for either species.  Decreases in 
velocity led to decreased O2 availability in the distal tissue regions, particularly at the end of the 
vessel.  When interactions between NO and O2 in the tissue region were not included, decreases 
in velocity led to large decreases in O2 availability at the distal, outer end o
F aximum O2 metabolic rate that was not dependent on NO and was 75% of the maximum
rate used in the simulations with interactions between NO and O2, O2 concentrations fell rapidly
to zero in the distal tissue regions.  Again, this provides evidence that NO acts as a protective 
mechanism to enhance O2 delivery.  Interactions between NO and O2 may also act to stabilize 
fluctuations in O2 availability in tissue regions due to changes in blood velocity.   
Inclusion of convective transport was shown to have several effects on NO and
transport and provides further evidence that NO may act as a protective mechanisms to
O ery.  Results from the study also suggest that since NO and O2 are not completely 
scavenged along the length of the vessel, that species concentrations from upstream vessels could 
have profound effects on downstream vessels.  The interactions between upstream and 
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downstream vessels suggests that future modeling work should include development of a 
compartmentalized model and eventually discrete architectural system models.        
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Table 5.  Parameters Used in Simulations of Convective Transport 
 
DEFINITION    VALUE(S)  
  
Vessel Geometry 
 
 Vessel Length   400.0 µm (Ye et al., 1994) 
 
Vessel Diameter   35.0 µm (Ye et al., 1994) 
 
Plasma Layer Thickness  2.0 µm  (Sharan and Popel, 2001) 
 
Endothelium   2.0 µm  (Buerk, 2001) 
 
Vascular Wall   9.0 µm  (Vadapalli et al, 2000) 
 
Tissue Thickness   100.0 µm (Vaughn et al., 1998; Butler, 1998) 
 
Hematocrit    45% 
 
Solubility Coefficient   1.3 µM Torr-1 (Buerk, 2001) 
 
Diffusion Coefficients 
 
 O2     2.8 x 10-5 cm2 s-1 (Ye et al., 1994) 
 
 NO     3.3 x 10-5 cm2 s-1 (Buerk, 2001) 
 
 
Maximum O2 Consumption (QMax)  
 
Vascular wall   3.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
Tissue    10.0 µM s-1 (Ye et al., 1994; Vadapalli et al., 2000) 
 
Hemoglobin Scavenging of NO  382.5 s-1  (Carlson and Comroe, 1958)  
  
Tissue Scavenging    1.0 s-1   (Vaughn et al., 1998,  
          Thomas et al., 2001) 
Km 
 eNOS    4.7 Torr  (Rengasamy & Johns, 1996) 
Maximum Velocity (VMax)  2800 – 3200 µm s-1 (Ye et al., 1994; Fung, 1997) 
Hemoglobin Concentration  5.3 x 10-6 µM        (Beard and Bassingthwaite, 2001) 
Inlet Blood Concentration  44.1 µM  (Vadapalli et al., 2000) 
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Dimensionless Variables 
 CRef    46 µM 
  0.1 µm 
R 135 µm
 L    400 µm 
 Ref  NO
 Ref      
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B 
A 
Figure 33.  NO and O2 concentration profiles with convective transport.  A.  Contour plot of NO 
concentration gradients in vessel and surrounding tissue.  B.  Contour plot of O2 gradient in vessel and 
surrounding tissue.  C.  NO concentration profile in axial direction along inner endothelial surface.  D.  
Axial O2 concentration profile at center of vessel.
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Figure 33  (continued) 
D 
C 
136 
B 
A
Figure 34.  Comparison of O2 concentration contours with and without parabolic inlet profile. 
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Figure 35.  Comparison of O  concentration contours at different blood O  concentrations (A) 44.1 µM,  
 
B 
A
2 2
(B) 35 µM, and (C) 60 µM. 
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Figure 35 (continued) 
C 
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plot with no interactions between NO and O2 in tissue.  Metabolic rate is 75% of 
maximum metabolic rate (QMax) used in previous simulations.
Figure 36.  O2 contour 
140 
Figure 37.  Comparison of O2 contours for different maximum blood velocities.  The blood velocity is  
2800 µm s-1 in the upper figure and 3200 µm s-1 in the lower figure.  The NO contour plot for the reduced 
velocity is depicted in C. 
A
B
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Figure 37 (continued) 
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A
Figure 38.  Comparison of O2 concentration contour profiles for different maximum NO production rates.  
In the upper figure (A), the maximum NO production rate is 25 µM s-1 while in the lower figure (B) the 
maximum NO production rate is 30 µM s-1.  The NO contour plot for decreased NO production rate is 
shown in (C).
